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Summary
In order to develop more efficient gene vectors a detailed understanding of the intracellular
behavior of these vectors is essential. Single particle tracking is a method that has proved
useful to elucidate biological processes on a single cell level. In this thesis single particle
tracking was used to study the internalization, intracellular trafficking, and endosomal release
of nonviral gene vectors consisting of plasmid DNA condensed with cationic polymers, so-
called polyplexes. A dual-color setup allowed separate detection of either polyplex and GFP-
labeled cellular structures or polymer and DNA.
In the first part of this work the internalization of different polyplexes into the cell was stud-
ied. The internalization process of epidermal growth factor (EGF) receptor-targeted particles
was investigated and compared with untargeted (PEG as well as LPEI) particles. Differences
in internalization between targeted and untargeted particles were revealed by trajectory anal-
ysis. Trajectories were generated by means of single particle tracking and represented the
movement of the particles during internalization. In these trajectories three different phases
were distinguished differing in morphology and instantaneous velocities. Analysis by means
of quenching experiments and mean square displacement as a function of time enabled a
biological interpretation of the three phases.
The first phase started directly after attachment of the particle to the cell membrane and
was characterized by a directed and a diffusional component. The directed component with
a value of vI = 0.015 ± 0.003 µm/s resulted from the retrograde movement of the cortical
actin cytoskeleton to which the particles are connected through transmembrane proteins. The
diffusional component of DI = 4 · 10−4 ± 4 · 10−4 µm2/s represented lateral diffusion of the
membrane-bound particles on the cell membrane. During phase I particles were internalized
into the cell. The second phase represented normal and confined motion in the cytoplasm.
The confinements varied between 0.3 and 2.0 µm in diameter. During the third phase active
transport along microtubules was visible, indicated by directed motion with a velocity of
vIII = 0.7 ± 0.4 µm/s.
Differences between targeted and untargeted particles were found in the duration of phase
I. Whereas EGFR-targeted particles showed phase I movement for some minutes, phase I
movement could last more than one hour for untargeted particles. This was reflected in the
percentage of internalized particles: 90% of the EGFR-targeted particles were internalized
within 10 minutes. Untargeted particles showed an extremely large spread but rarely more
than 80% internalization even after 80 minutes.
For the first time, these results give a detailed view on the different phases during internal-
ization and subsequent intracellular trafficking of polyplexes. Moreover these results show
that targeting by means of a ligand leads to faster and more efficient internalization.

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In the second part of this study the endosomal release of polyplexes was studied. Endosomal
release was induced by means of photosensitizer excitation generating singlet oxygen and
subsequently membrane damage.
The visualization of endosomal release was first proved with a dextran fluid phase marker.
Upon photosensitizer activation the endosomal content was released within 100 ms.
In order to image the endosomal release of polyplexes, plasmid DNA and polymer were
labeled with different colors. Three different polymers were used to condense the DNA: LPEI,
PLL and PDL. These differ in endosomal buffering capacity, biodegradability and DNA binding
affinity.
Differences in release behavior were observed between the particles themselves as well as
between polymer and DNA. LPEI particles showed distinguishable behavior for polymer and
DNA suggesting dissociation of the complex before endosomal release. LPEI quickly diffused
away from the endosome due to its small size. DNA was not degraded but remained intact
and immobile in the cytoplasm. For PLL particles polymer and DNA showed similar behavior.
PLL quickly diffused away from the endosome. DNA was degraded and also diffused into the
cytoplasm. In contrast, PDL particles remained intact in the endosome. In this case, both
PDL and DNA did not diffuse out of the endosome but remained colocalized in the endosomal
region, indicating intact particles.
These observations suggest differences in the final destination of the complexes. LPEI
particles remained in endosomes, PLL and PDL particles were transported towards lysosomes.
Apart from increasing endosomal release, photosensitizer activation is known to have side
effects on cells. In this study the effect on microtubules, actin, Rab5 and Rab9 proteins and
endosomal motion was examined.
In tubulin-GFP expressing cells reduced microtubule dynamics was observed in combi-
nation with an intact microtubule skeleton. This may be explained by inhibition of poly-
merization and depolymerization of microtubules due to photosensitizer binding to tubulin
heterodimers. In contrast to microtubules, no effect of the photosensitizer on actin was ob-
served.
A change in location of Rab5 and Rab9 proteins was observed upon photosensitizer acti-
vation. Rab5 and Rab9 GFP-marked single endosomes, representing early and late endosomes
respectively, disappeared upon singlet oxygen production concomitant with photosensitizer
activation. Most probably the Rab proteins changed from their membrane-bound to their cy-
tosolic conformation due to singlet oxygen damage of the connection between protein and
membrane.
A last side effect concerned the motion of the endosomes. Upon photosensitizer activation
an immediate stop of endosomal motion was observed. This may be related to the change in
conformation of the Rab proteins, since Rab proteins play a role in the connection between
endosome and microtubules. By transformation of the Rab proteins into their cytosolic form
the connection between endosome and microtubule is lost and endosomal motion is stopped.
Combining the data in this thesis new insights into the mechanism of internalization and
intracellular trafficking are obtained. Single particle tracking has proved to be an excellent
tool in order to study the behavior of single gene vectors in detail. The new insights can be
used to develop more effective gene carriers to enhance the efficacy of nonviral vectors.

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1. Introduction
"Viren, die das Auge retten" (Viruses that rescue the eye) was the title of an article on the
front page of the Süddeutsche Zeitung on the 28th of April 2008 [1]. Stephen Howarth, an
18-year-old British boy has suffered from Leber’s congenital amaurosis since birth. This
illness is an inherited disorder causing severe vision loss, especially in the dark [2]. Vision
generally deteriorates over time and patients become blind when they are 30–40 years old.
Stephen Howarth and five other patients were treated in a gene therapeutic clinical trial and
showed improved visual function after treatment [3, 4].
This is the most recent success in the 20-year-old history of gene therapy trials, starting
with a trial on advanced melanoma in 1989 [5]. Gene therapy is based on the introduction of
a new, healthy gene into cells lacking expression of this gene. The new gene is introduced
into the cell nucleus and can either interfere with a malfunctioning gene’s function, restore a
lost function or initiate a new function [6]. In this way normal gene expression by the target
cells is induced.
There are two different ways to introduce a gene into the cell nucleus: with the help
of viruses (viral vectors) or by means of nonviral vectors. In case of Stephen Howarth, an
adeno-associated virus was used to carry the gene into the nucleus [3, 4]. In general, viral
vectors induce a high expression of the target gene. Nevertheless, their disadvantage is the
immunogenic response of the body upon administration. For this reason, a lot of research
has been done on alternative vectors, so-called nonviral vectors.
Nonviral vectors consist of plasmid DNA condensed by either a cationic lipid, forming
a lipoplex, or a cationic polymer in which case the complex is called polyplex. This study
concentrates on the behavior of polyplexes. Until now, no clinical trials have been done using
polyplexes. The main reason for this is the low transfection efficiency of these vectors. In
order to induce gene expression, the DNA has to enter the cell nucleus. On its way to the
cell nucleus there are several barriers to overcome. First the vector has to enter the cell. For
polyplexes this mostly occurs via endocytosis [7]. Second, the complex has to escape the
endosome. Third, the DNA has to be transported to the nucleus and fourth it has to enter the
nucleus. Viruses have evolved specialized mechanisms to overcome these barriers. Nonviral
vectors in contrast have to be modified chemically. In order to make nonviral vectors more
efficient the different barriers have to be characterized in detail.
The first cellular barrier a gene vector encounters is the plasma membrane. Polyplexes
consisting of DNA condensed with polyethyleneimine PEI are most probably internalized via
HSPGs (heparan sulfate proteoglycans) present in the cell membrane [8–11]. Polyplexes
equipped with a ligand targeting a specific receptor in the cell membrane showed a much
higher transfection efficiency [12–14] and are expected to be internalized via a more efficient
mechanism [15, 16]. Conventional biological techniques to unravel the difference in inter-
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nalization between targeted and untargeted particles provide average or ensemble values. In
this study the internalization process of both untargeted and targeted particles is studied on a
single cell level. By means of single particle tracking the internalization of individual gene
vectors is followed and differences between untargeted and targeted particles are observed in
real time.
Another barrier on the way towards the nucleus constitutes the escape from the endosome.
Polyplexes are known to be internalized into the cell via endocytosis. Thus, an internalized
particle is entrapped in an endosome. In order to deliver the DNA into the cell nucleus the par-
ticle has to escape from the endosome. There are different mechanisms to induce escape from
the endosome, e.g. using peptides or polymers that react with the membrane and create pores
in it [7, 14]. In this study endosomal release is induced by excitation of a membrane-bound
photosensitizer and subsequent singlet oxygen production. By means of this photochemi-
cal treatment the endosomal membrane is damaged and thus the polyplex is released. This
treatment showed an increase in transfection efficiency [17–19]. However, the detailed mech-
anism has not yet been unraveled. By means of single particle tracking the mechanism of
endosomal release of different polyplexes is studied in real time.
The last part of this study concentrates on the side effects of the photochemical treatment.
Excitation of the photosensitizer induces singlet oxygen production which is toxic to several
cellular components [20]. Here, the influence of the photosensitizer on microtubules, actin,
Rab5 and Rab9 proteins and on endosomal motion is studied.
This thesis is structured as follows: the theory chapter following the introduction gives an
overview of the basic biological background of this thesis. In chapter 3 the different experi-
mental methods are described. Chapter 4 describes the first set of experiments concerning the
internalization process of receptor-targeted and untargeted particles. The results described in
this chapter are published in Molecular Therapy [21]. The process of endosomal release,
induced by internalization and excitation of a photosensitizer, was imaged for three different
gene vectors and is described in chapter 5. Finally, side effects on the cell of the use of pho-
tosensitizer are described in chapter 6. These two chapters are submitted for publication in
the Journal of Controlled Release.
2
2. Principles of gene transfer
In this chapter an overview is presented of the biological background of this thesis. It starts
with an introduction into gene therapy and different gene vectors. Then the cellular struc-
tures and possible barriers are described that a gene vector may encounter on its way from
attachment to the cell membrane towards the cell nucleus. This includes a description of
the different pathways by which a vector may be internalized into the cell, the endosomes in
which the vector is transported inside the cell, release from the endosome, transport into the
nucleus and finally expression of the target gene.
2.1 Therapeutic gene transfer
The discovery of DNA by Watson and Crick in 1953 [22] enables us to change the characteris-
tics of a cell on a basic level: by modifying the genome of the cell we can alter its phenotype.
Gene therapy makes use of this principle by correction of genetic disorders through inter-
action with a malfunctioning gene. DNA sequences (the "healthy" gene) are introduced into
the cell nucleus of those cells that are supposed to regulate normal expression of the (mal-
functioning) gene. The newly introduced gene can either interfere with a gene’s function,
restore a lost function or initiate a new function [6] to induce normal gene expression by the
target cells. The advantage of gene therapy is the potential elimination of the disease state
instead of alleviating the symptoms of the disease, as conventional medicines do. Obviously,
diseases suitable for gene therapy are diseases caused by a genetic disorder [23].
The first experiments on cloning of mammalian genes in the late 1970s and early 1980s
are commonly seen as the precursors of gene therapy [24] resulting in the first human gene
therapy trial in 1989 [5]. Although since then more than 1300 gene therapy clinical trials have
been performed, in Europe as well as in the USA no gene therapeutic medicine is available
yet [25]. A major setback for gene therapy was the death of Jesse Gelsinger in 1999 during a
clinical trial with an adenovirus-based gene vector [26]. Another unfortunate case occurred in
2002 when two children, treated for X-linked severe combined immunodeficiency (SCID-X1),
developed leukemia [27]. Nonetheless, the treatment was successful in seven other patients.
In the last years, positive results were obtained in different trials for the treatment of chronic
granulomatous disease (an inherited primary immunodeficiency that affects phagocytes) [28],
metastatic melanoma [29], and Parkinson’s disease [25]. Most recently, a clinical trial on
retinal dystrophy was performed and improved visual function was observed [3, 4].
Two different techniques of gene delivery exist: ex vivo and in vivo delivery [6, 30]. Ex vivo
gene delivery involves isolation of cells from a patient, establishment of the cells in tissue
culture, gene delivery to these cells and placement of the cells back into the patient. For in
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vivo gene delivery genes or gene vectors are directly delivered to cells in the patient by local
or intravenous injection. Both delivery mechanisms put requirements on the gene vectors
that will be discussed in the next sections.
2.2 Overview of different gene vectors
In order to deliver genes into target cells, different possible vectors exist. The most well-
known and in most clinical trials used is a viral vector. A viral vector is based on a replication-
defective virus where part of the genome is replaced by therapeutic genes. The most com-
monly used viruses are adenoviruses and retroviruses [25]. A second class of vectors consti-
tutes the nonviral vectors. They consist of a cationic compound condensing the anionic DNA.
This cationic compound can be a polymer, in which case the gene vector is called a polyplex
or it can be a lipid, and is then named lipoplex. When both lipid and polymer are used, the
complex is termed lipopolyplex. The third class of vectors is naked DNA. Naked DNA can be
injected directly into certain tissues, e.g., muscle tissue. Recently, gene therapy trials have
started to use siRNA to (down)regulate expression of target genes [25]. The advantage of the
use of siRNA is that the vector does not need to enter the cell nucleus [31]. When in the cy-
tosol, siRNA degrades the complementary mRNA molecules that are released from the nucleus
following transcription.
2.2.1 Viral vectors
Viral vectors are replication-defective viruses where part of the genome is replaced by thera-
peutic genes. The size of the gene that can be delivered is limited to the size of the original
genome of the virus. The large advantage of viral vectors is their high transduction efficiency.
Viral vectors can transduce cells in vitro with 100–10000 viral genomes per cell, whereas for
nonviral vectors 100 times more gene copies per cell are needed [32]. In addition, viral vec-
tors are able to transfect a large fraction of a defined cell population [33]. For these reasons,
most gene therapy trials up to 2007 have used viral vectors (67%) [25].
A big problem in the use of viral vectors is the immunogenic response of the body upon
administration of the vector. An immune reaction can either be innate and follow immedi-
ately after administration, or it can be adapted. In the latter case, the immune reaction is
most prominent after the second or third administration of the vector. The immune response
is strongly dependent on the viral vector used. Adenoviral vectors induce very strong im-
mune responses, lentiviral and retroviral vectors in contrast almost none [34]. The vehement
immune reaction upon administration of adenovirus-based vectors was the cause of death of
Jesse Gelsinger in 1999 [26].
A second disadvantage of viral vectors is their affinity for a particular tissue and cell type,
called tropism. Specific proteins, present on the coat of viruses, bind to defined receptors
expressed on the cell membrane of the target cells. Depending on the virus, these surface
proteins and thus their tropism differs. For use in gene therapy a change in tropism may be
necessary, since the gene need not necessarily be delivered to the cell type specified by the
surface proteins on the virus coat [35]. The efficient transduction of viruses is often caused
by their specific tropism together with an infection process which is optimized for the target
tissue. Therefore, changing the tropism of a virus may influence the transduction efficiency
as well [36].
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The third disadvantage of viral vectors is the preferential integration of the genome into
an existing gene in the host genome [37]. In this way, the genome of the host cell is altered
in an uncontrolled fashion. Treatment of SCID-X1 in the aforementioned gene therapy trial
by means of a retrovirus resulted in integration of a therapeutic gene near an oncolytic gene
causing leukemia [27]. On the other hand, the integration into the host genome has the
advantage of often leading to stable expression of the gene [38].
2.2.2 Nonviral vectors
A general characteristic of nonviral vectors is that they do not use a virus to deliver the DNA
into the target cell. The occurrence of serious side effects of viral vectors has motivated
an increase in the research on nonviral vectors. The big advantage of nonviral vectors is
their biosafety. Whereas viral vectors easily provoke an immune response and can alter the
genome of the host cell, nonviral vectors do not incite such a strong immune reaction and
will very rarely insert into the host genome. Further advantages of nonviral over viral vectors
are the easy chemical modification, the low cost and the large size of genetic material that
can be delivered to the target cell. Unfortunately, nonviral vectors are still less efficient than
viral vectors in delivery of DNA to the cytoplasm and subsequently to the nucleus.
Different classes of nonviral vectors can be distinguished. The first category comprises naked
DNA. Via microinjection naked DNA can be delivered into, e.g, muscle cells. Although naked
DNA can easily be degraded in the cytoplasm by DNases, clinical trials with naked DNA have
been performed [25].
The second class consists of DNA condensed with cationic lipids to protect DNA from
degradation, these vectors are called lipoplexes. A cationic lipid is a positively charged am-
phiphile containing a hydrophilic head and hydrophobic tail. In aqueous solution, above
a critical vesicle concentration cationic lipids spontaneously form micelles (consisting of a
monolayer of the lipid) or bilayer vesicles. A multilamellar vesicle is formed when different
bilayers surround each other. Bilayers and multilamellar vesicles are known as liposomes.
The overall charge of the liposome is positive and via electrostatic interactions it is bound to
the negatively charged DNA [39].
The third class of nonviral vectors is called polyplexes and contains DNA and a condensing
polymer for DNA protection. Many different possible polymers are under current investiga-
tion. They can be separated into biodegradable and nonbiodegradable polymers. Biodegrad-
able polymers include chitosan (a linear aminopolysaccharide, based on the naturally occur-
ring chitin), polyesters and poly-L-lysine (PLL). Nonbiodegradable polymers are for example
polyethyleneimine PEI, poly-D-lysine (PDL) and dendrimers. This study concentrates espe-
cially on PEI, PLL and PDL. All three condense DNA by interaction of their protonated amine
groups with the phosphate groups of DNA.
The chemical structure of PEI is presented in figure 2.1a. It is available in two different
forms: linear PEI (LPEI) and branched PEI (BPEI). Condensation of DNA with PEI (both LPEI
and BPEI) results in particles with a positive net charge, because of the excess of PEI. PEI
particles have been shown to give one of the highest transfection efficiencies compared to
condensation with other cationic polymers [40] whereby the linear form of PEI has been
shown to give even higher transfection efficiencies than its branched counterpart [41]. For
this reason a lot of research has been done on PEI (both linear and branched) and it has
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(a) Linear polyethyleneimine (b) Polylysine
(c) Polyethyleneglycol
Figure 2.1: Chemical structure of linear polyethyleneimine, polylysine and polyethylenegly-
col.
become something like a gold standard of nonviral gene delivery [42]. The high transfection
efficiency of PEI compared to other polymers is thought to be caused by its high buffering
ability; since every third atom of PEI is a protonatable amino nitrogen atom, PEI has a high
ability to capture protons [43]. In endosomes, this buffering ability prevents the transition to
lysosomes: the so-called "proton sponge" effect (see section 2.5.1) [44, 45].
Poly-L-lysine is one of the first polymers characterized as a DNA-condensing polymer,
enabling DNA transfer into the cell [46]. Figure 2.1b shows the chemical structure of polyly-
sine. It is a linear polypeptide with repeating units of the L-amino acid lysine and is thus
biodegradable. The peptide structure can be degraded by peptidases present in the lysosome.
This biodegradability is the big advantage of PLL compared to PEI. Unfortunately, the trans-
fection efficiencies of PLL are lower. Moreover, PLL is not biologically inert. It is known to
have an influence on membrane permeability [47] and on the internalization mechanism by
enhancing pino- and phagocytosis [48, 49]. Additionally polylysine has a lytic activity on
cells [50]. The stereoisomer poly-D-lysine (PDL) is also capable of condensing DNA [51]. PDL
is not biodegradable since D-amino acids are not naturally present in the cell, and so cannot
be degraded by peptidases.
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All cationic polyplexes have the disadvantage of inducing an immune reaction in vivo by
activation of the complement system [52]. Upon intravenous administration, PEI interacts
with albumin and red blood cells, and forms aggregates that end up in the lung, causing an
embolism [53]. PLL polyplexes also react with red blood cells, but upon binding to plasma
proteins, PLL is rapidly cleared from the blood stream [54]. To avoid these unwanted side ef-
fects, positively charged polyplexes can be shielded with polyethylene glycol (PEG, chemical
structure presented in figure 2.1c) [53]. The electrically neutral PEG shield reduces interac-
tions with blood components.
Intravenously delivered PEI particles lead to high gene expression in the lung and lower ex-
pression in other organs like spleen, heart, liver and kidneys [55]. Since these organs may not
be the target tissue, enhanced delivery towards a defined tissue is needed. This is achieved by
coupling a ligand to the gene vector. The ligand binds specifically to a well-defined receptor
that is expressed on the cell surface of the target tissue. In this way, unspecific binding to
other tissues is avoided and the gene vector is delivered efficiently to the desired tissue. An
example of a ligand is the epidermal growth factor (EGF) which binds to the epidermal growth
factor receptor (EGFR) which is overexpressed on tumors. The effect of EGF receptor targeting
has indeed already been demonstrated in vivo [56].
2.3 Internalization pathways
In general, polyplexes enter the cell by means of endocytosis. For most eukaryotic cells it
is the common process to internalize extracellular molecules and larger substances. Endo-
cytic processes can be divided into two different classes: phagocytosis ("cell eating") and
pinocytosis ("cell drinking"). Pinocytosis may occur by means of three different mecha-
nisms: macropinocytosis, clathrin-dependent, and lipid raft-dependent endocytosis (whereby
lipid raft-dependent endocytosis can be separated into caveolin-dependent and caveolin-in-
dependent mechanisms). In the next sections phagocytosis and the different subclasses of
pinocytosis will be discussed. A diagram illustrating the different pathways is presented in
figure 2.2.
2.3.1 Phagocytosis
Particles larger than ∼500 nm in diameter are often internalized by phagocytosis [58]. Upon
binding of the particle to the plasma membrane, specialized surface receptors are activated
and trigger local actin polymerization. Driven by this polymerization the plasma membrane
zippers up closely around the particle so that the particle is engulfed by the plasma membrane.
The membrane closes up and the phagosome is sealed off from the membrane and is trans-
ported towards the cytosol. Phagocytosis is restricted to so-called phagocytes, in mammals
these are, e.g., macrophages and neutrophils [59, p.788].
2.3.2 Macropinocytosis
Macropinocytosis occurs by cell membrane ruﬄing induced by growth factors or other sig-
nals. As with phagocytosis, actin plays a major role in this process [57]. The cell membrane
is pushed upwards by local actin polymerization in protrusions perpendicular to the cell mem-
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Figure 2.2: Schematic representation of the different internalization pathways as described
in the following subsections. Phagocytosis and pinocytosis are the main classes of endocy-
tosis. Three different mechanisms of pinocytosis exist: macropinocytosis, clathrin-dependent
endocytosis and lipid raft-dependent endocytosis. Figure adapted from [57].
brane. Unlike phagocytosis, the cell membrane is not zippered up around a particle, but the
protrusions collapse onto and fuse with the cell membrane (see figure 2.2). Hereby large and
morphologically heterogeneous endocytic vesicles are formed that are typically 0.5–2.5 µm
in diameter [60]. By means of macropinocytosis especially macromolecules in large volumes
of extracellular fluid are internalized into the cell.
2.3.3 Clathrin-dependent endocytosis
Clathrin-dependent or clathrin-mediated endocytosis (CME) is a form of pinocytosis and is
dependent on the protein clathrin. Clathrin consists of three heavy and light chains forming
a three-legged structure, a triskelion. By self-assembly, triskelions can form a cage. The
first stage in CME is the formation of a coated pit. This is induced by binding of so-called
adaptor or assembly proteins (AP’s) to the cytosolic site of cell surface receptors [61]. The
clustering of AP-receptor complexes triggers clathrin binding to the complexes. Subsequent
self-assembly of clathrin into a cage induces the curvature of the membrane, which now rep-
resents a coated pit [60,62]. The second stage in clathrin-mediated endocytosis is scission of
the vesicle. After clathrin assembly and invagination of the membrane, the GTPase dynamin
is rapidly transported towards the small extracellular opening of the invaginated vesicle [63].
Dynamin, together with polymerizing actin, then bring about the detachment from the plasma
membrane [64]. Once the vesicle is internalized, the clathrin coat dissociates from the vesi-
cle.
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For the Low Density Lipoprotein receptor and the transferrin receptor it was shown that
ligands bind to a preexisting coated pit [65] that is present as a stationary structure on the cell
surface [66]. However, not all receptors are present in coated pits on the cell surface. The
epidermal growth factor (EGF) receptor clusters only upon ligand binding [67–69], followed
by clathrin redistribution to the cell periphery [70]. A comparable behavior is observed for
the endocytosis of influenza viruses [71].
2.3.4 Lipid raft-dependent endocytosis
In addition to the clathrin-mediated pathway, the existence of several clathrin-independent,
but lipid raft-dependent endocytic pathways has been demonstrated (for a review on this
subject, see Nichols et al. [72] or Sandvig et al. [73]). These pathways are distinctly less well
understood than clathrin-dependent endocytosis and contrary views exist on the importance
and abundance of several pathways [73–75].
For all clathrin-independent pathways the presence of lipid rafts1 was confirmed, as far
as biochemical assays have been carried out [72]. The best characterized of these pathways
is caveolin-mediated endocytosis. Although the extent of uptake via this pathway is con-
troversial [74–76], both SV40 virus and cholera toxin are known to use caveolae for their
internalization [77, 78]. Caveolae are flask-shaped invaginations in the plasma membrane
with a size of 50–80 nm in diameter, that are highly immobile and rich in caveolin, a dimeric
cholesterol-binding membrane-associated protein. The endocytic mechanism of caveolae re-
mains to be elucidated but the entry of the SV40 virus revealed uptake into organelles that
were distinct from classical endosomes and were called ’caveosomes’ [79]. Evidence also
exists that the protein dynamin is involved in caveolar endocytosis [80].
Several other clathrin-independent pathways have been demonstrated which can be clas-
sified as dynamin-dependent or dynamin-independent. Many involve small GTPases such as
RhoA, CDC42 or ARF6 [81]. Some of them show a dependence on the endocytic protein flotillin.
The detailed mechanism of these pathways is still unclear and more research has to be done
to elucidate it.
2.4 Endosomal transport
Once internalized into the cell via endocytosis, a gene vector is entrapped in an endosome.
The main function of the endosome is sorting out cargo for degradation and cargo for recy-
cling. This occurs immediately after internalization, in the early endosome. Cargo designated
for degradation is transported towards late endosomes and subsequently to lysosomes where
acid hydrolases breakdown macromolecules into smaller subunits. In the following the differ-
ent endosomal compartments are described through which a gene vector can be transported.
2.4.1 Early endosomes
Immediately after internalization by endocytosis, particles are entrapped in early endosomes.
These are vesicles with a diameter of 0.3–0.4 µm with extending narrow (< 60 nm) tubules
[82] and a pH of around 6.4 [83]. The primary function of early endosomes is sorting of
1 dynamic, detergent-resistant regions of the plasma membrane enriched in cholesterol and lipids
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cargo. The slightly acidic pH induces dissociation of several ligands from their receptors
(e.g. transferrin) [83]. These receptors are segregated into the tubular extensions which are
pinched off from the early endosome and move back to the plasma membrane to recycle the
receptors (these endosomes are called recycling endosomes). Not all receptors are recycled
in this way. Some remain, together with other cargo that is to be degraded, in the spherical
domain of the early endosomes. After pinching off from the tubular domain, the spherical
domain fuses with other endosomes (homotypic fusion) such that cargo is concentrated in
fewer and larger endosomes [84]. These endosomes are transported towards the perinuclear
area along microtubules.
Early endosomes can easily be distinguished from late endosomes or lysosomes by the
protein early endosome antigen 1, EEA1 [85]. EEA1 is involved in early endosome docking
and fusion [86] and is associated with early endosomes through binding to another protein
especially present on early endosomes, Rab5. Rab5 is often used as a marker for early en-
dosomes. It is a small GTPase which is known to regulate fusion events between different
early endosomes [87, 88]. It also plays a role in the movement of early endosomes along
microtubules [89]. Displacement of Rab5 by the GTPase Rab7 in the perinuclear area induces
the transition of early endosomes to late endosomes [84].
2.4.2 Late endosomes
In the perinuclear area, after homotypic fusion, early endosomes are transformed to late en-
dosomes when Rab5 is displaced by Rab7. The pH of late endosomes (lying between 5 and
6 [90]) is lower than in early endosomes. Late endosomes, in contrast to early endosomes, do
not exist as a single bilayer vesicle, but consist of several intralumenal vesicles enveloped by
an outer membrane. Late endosomes are therefore also called multivesicular bodies (MVB).
The intralumenal vesicles are generated by budding of a vesicle from the original membrane,
in the same way as endosomes bud from the plasma membrane. The membrane of intralu-
menal vesicles contains mannose 6-phosphate receptors which distinguishes late endosomes
from lysosomes [91]. MVBs sort cargo for degradation and enable fusion with lysosomes [92].
Intralumenal vesicles can in rare cases be recycled back to the cytosol [93,94]. In most cases
the content of intralumenal vesicles is delivered to lysosomes. For the transition from late
endosomes to lysosomes the contents of both compartments are fused, which was shown
by means of confocal microscopy by Bright et al. [95]. This occurred 10–15 minutes after
incubation of the cell with dextran.
Rab9 is another member of the Rab family of Rab GTPases. Rab9 is located on the surface
of late endosomes and regulates the transport of mannose 6-phosphate receptors to the trans-
Golgi network [96]. Rab9 also influences the size of the late endosome [97]. Therefore, Rab9
can be used as a marker for late endosomes.
2.4.3 Lysosomes
Lysosomes are considered as membrane-bound organelles storing a variety of acid hydro-
lases [98]. They are ∼0.5 µm in diameter, have a heterogeneous morphology and are con-
centrated in the perinuclear area of the cell. Lysosomes are distinguished from late endo-
somes by the lack of mannose 6-phosphate receptors. By means of proton-pumping vac-
uolar ATPases, the pH of lysosomes is maintained at 4.6–5.0 [90] which activates the acid
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hydrolases. By fusion with late endosomes, a hybrid organelle is formed which is the major
compartment for degradation of cargo [99]. In lysosomes different enzymes are present that
can degrade cargo into smaller subunits. Examples are peptidases and glycosidases that can
break down polypeptides and glycans or DNases that can degrade DNA into nucleotides. Since
enzymes act isomerically specific, only cargo comprised of L-amino acids can be degraded.
The smaller subunits are transported out of the lysosome by diffusion and carrier-mediated
transport [100].
2.5 Endosomal release
When a gene vector reaches the lysosome, the DNA is degraded by DNases present in the
lysosome and active at low pH. To avoid this degradation, the vector has to escape from the
(early or late) endosome. Different techniques have been developed to enhance endosomal
escape. One example is the use of peptides or polymers that change their conformation upon
a decrease in pH, associate with the membrane and in this way induce membrane damage
[7]. They can be coupled to gene vectors. One example is melittin, a cytolytic peptide
extracted from bee venom that induces transmembrane pores in lipid bilayers [14,101]. Two
additional possibilities to enhance endosomal release are the "proton sponge" effect and the
use of photosensitizers. These are discussed in detail below.
2.5.1 Proton sponge hypothesis
The term "proton sponge" was first introduced in connection with the buffering ability of PEI
by Boussif et al. [44]. Since every third atom of PEI is a protonable amino nitrogen atom
(see figure 2.1a), PEI is an effective "proton sponge". The overall protonation level of PEI
increases from 20% to 45% as the pH decreases from 7 to 5 [43]. In case PEI particles are
internalized into endosomes, this large buffering capacity leads to reduced acidification of
the endosomes and therefore to avoidance of trafficking to lysosomes [102]. In endosomes, a
vacuolar ATPase pump brings H+ atoms inside the endosome and simultaneously Cl− enters
the cell [90]. Due to the buffering capacity of PEI, the influx of protons and concomitant
Cl− ions is large [45]. Thus the osmotic pressure of the endosome increases and leads to
increased passive diffusion of H2O molecules into the endosome. The endosome increases
in size, so-called osmotic swelling, whereupon lysis of the endosome occurs [45]. In this
way, the gene vector is released from the endosome without being degraded by lysosomal
enzymes. This makes PEI an efficient gene carrier.
2.5.2 Photoinduced release
Photoinduced endosomal release makes use of the generation of singlet oxygen by excitation
of a photosensitizer. The principle is illustrated in figure 2.3. A photosensitizer, usually a
porphyrin, is added to the cell together with the gene vector. The photosensitizer binds to the
plasma membrane and is internalized via endocytosis [103]. By illumination with light of a
defined wavelength, the photosensitizer is excited into a singlet state and intersystem crosses
to its lowest excited triplet state [104]. This triplet state can be quenched by molecular oxygen
resulting in generation of singlet oxygen. Singlet oxygen is a highly reactive species with a
lifetime of maximal 4 µs in H2O [105] and a diffusion radius of ∼50 nm [106]. It is known
11
P   
Figure 2.3: Mechanism of photoinduced endosomal release. The photosensitizer (red) binds
to the plasma membrane and is endocytosed together with the gene vectors (blue). Upon ac-
tivation of the photosensitizer, singlet oxygen is generated and the endosomal membrane is
damaged. The endosomal cargo is then released into the cytoplasm.
to oxidize membrane lipids, proteins, amino acids and several other organic macromolecules
[20] close to the site of generation. Since these molecules are present in the endosomal
membrane, the membrane is damaged enabling the cargo to get out of the endosome [104].
2.6 Nuclear import
Although endosomal release is a large barrier in gene transfer, transport towards the nucleus
and nuclear entry are at least as important. Late endosomes are localized close to the nucleus
and endosomal release may therefore release the DNA close to the nucleus. Due to its size,
transport of the plasmid DNA to the nucleus is extremely slow [107, 108]. However, most
research has focused on nuclear import rather than on the transportation towards the nucleus.
In general, two possibilities exist for a nonviral vector to enter the nucleus. A first possi-
bility exists when the cell undergoes mitosis. The nucleus is separated from the cytosol via
a double membrane, called the nuclear envelope. During mitosis, the nuclear envelope com-
pletely disassembles [109] and the gene vector can enter the nucleus via diffusion. Indeed,
gene transfer has been shown to be dependent on cell cycle [110]. Entry into the nucleus
during mitosis has been shown to be the major route for PEI particles [111].
The second possibility comprises nuclear import via small pores in the envelope, so-
called nuclear pore complexes (NPC). The upper size limit for passive diffusion through the
NPC is ∼ 50 kDa [112]. Thus, plasmid DNA must make use of active transport for entry
into the nucleus and therefore a nuclear localization signal (NLS) is needed which targets the
plasmid towards the nucleus. This nuclear localization signal can be covalently attached to
the DNA and interacts with the nuclear pore complex to facilitate entry of the DNA to the
nucleus [113–115].
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2.7 Gene expression
A most important aspect in gene therapy is the sustained expression of the therapeutic gene.
Expression may either be transient or stable. Transient expression is reduced over time be-
cause the newly introduced gene does not replicate into new cells. Often duration of expres-
sion is related to the form in which the gene is present in the nucleus. The gene can be
integrated in the chromosome of the host cell or it may be present as a separate molecule.
In general, plasmids from nonviral vectors exist as a separate molecule and they may not be
replicated when the cell replicates [38]. Integrating genes into the chromosomes of the cell
may induce sustained expression but a site-specific integration of the genes in the chromo-
some is difficult and there is a risk of integration into an existing gene [37]. Some plasmids
are able to replicate extrachromosomally, they are called episomes.
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3. Experimental methods
In this chapter the experimental techniques used in this thesis are explained. It starts with
a description of polyplex synthesis and of cell culture. Then the principles of widefield
fluorescence microscopy are described and the experimental setup is shown. The technique
used to analyze the obtained video streams is called single particle tracking and is explained
in section 3.5. The last section describes quenching which was used to distinguish intra- and
extracellular particles.
3.1 Synthesis of polyplexes
All polyplexes in this thesis consist of plasmid DNA condensed by a cationic polymer via
electrostatical interactions. In order to visualize polymer as well as DNA both components
were labeled with a fluorescent dye. For the experiments described in chapter 4 only DNA
was labeled. To form a polyplex rapid mixing of polymer and DNA is sufficient [116]. Figure
3.1 shows the synthesis of the polyplexes, as described in detail in the following sections. The
size of the polyplex depends on the solvent: mixing in heparan buffered glucose results in
particles of 100–140 nm, in heparan buffered saline particles grow to a size of 1–1.5 µm [116].
After mixing, the polyplexes were purified by size exclusion chromatography.
3.1.1 DNA labeling
Plasmid DNA (pCMV Luc, ∼ 5500 bp, described in [117]) was covalently labeled with the
fluorophores cy3 or cy5 using the Label IT kits (MIRUS, Madison, WI) according to the
Figure 3.1: Synthesis of LPEI, PEG and EGF particles. PLL and PDL particles are synthesized
analogous to LPEI particles. Upon rapid mixing of DNA and cationic polymer polyplexes are
formed.
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manufacturer’s instructions. 20 µg of DNA were diluted with 1X Buffer A to a final volume
of 195 µl. After addition of 5 µl reconstituted Label IT reagent, the reaction mixture was
incubated for 3 hours at 37◦C. To precipitate labeled DNA 550 µl of ice-cold 100% ethanol
and 22 µl of 3 M sodium acetate were added. The solution was then mixed and placed
at −20◦C overnight. Subsequent centrifugation at 16000 rpm for 1 hour at 4◦C allowed
removal of unreacted label in the supernatant. The pellet was gently washed with ice-cold
70% ethanol and centrifuged again. Labeled DNA was allowed to dry for 5 minutes and
finally resuspended in sterile HEPES-buffered glucose (HBG, 20 mM HEPES, glucose mass
fraction of 5%, pH 7.1). The concentration of cy3 and cy5 was measured by absorption
at 550 nm and 650 nm, respectively. The extinction coefficients of these fluorophores are:
cy3, 550nm = 150000 lmol−1cm−1 and cy5, 650nm = 250000 lmol−1cm−1. DNA was quantified
by measuring the absorbance at 260 nm. The ratio of the absorbance at 260 nm:280 nm is an
index for DNA purity. On average, one dye molecule was bound per 50 to 100 DNA basepairs.
3.1.2 Polymer labeling
For the experiments described in chapters 5 and 6 double-labeled particles were used con-
sisting of cy5-labeled DNA and polymer labeled with Alexa Fluor 488 carboxylic acid, suc-
cinimidyl ester (A488, Invitrogen, Karlsruhe, Germany). The three polymers used to con-
dense DNA are linear polyethyleneimine (LPEI, MW 22 kDa, Euromedex, Souffelweyersheim,
France), poly-L-lysine (PLL-HBr, MW 32 kDa, Sigma Aldrich, Munich, Germany) and poly-
D-lysine (PDL-HBr, MW 35 kDa, Sigma Aldrich, Munich, Germany).
For LPEI labeling, A488 was dissolved in DMSO at a final concentration of 10 mg/ml. 1
mg (1.55 µmol) A488 was mixed with 8.54 mg (0.388 µmol) LPEI. The volume was adjusted
to 1 ml with HEPES-buffered saline (HBS, 20 mM HEPES, pH 7.4, 150 mM NaCl). The reaction
was incubated light-protected for 1 hour at room temperature on a rotation wheel. In order
to separate labeled LPEI from free A488, size exclusion chromatography was performed with
a gel filtration column (Sephadex G-25 superfine; HR10/30 column, Amersham Biosciences,
Germany) preequilibrated with HBS. The amount of A488 and of LPEI was determined spec-
trophotometrically at 495 nm and via a copper complex assay, respectively. The molar ratio
of LPEI:A488 was 1:2.2.
Poly-L-lysine (PLL) and poly-D-lysine (PDL) were labeled according to the labeling pro-
tocol for LPEI, with slight modifications. The concentration of A488 dissolved in waterfree
DMSO was 5 mg/ml. 0.5 mg (0.775 µmol) of A488 were added to 625 µl HEPES (20 mM,
pH 8.0) containing either 12.5 mg (0.391 µmol) PLL-HBr or 13.5 mg (0.391 µmol) PDL-
HBr. The reaction was incubated light-protected for 1 hour at room temperature on a rotation
wheel. Size exclusion chromatography was performed with a gel filtration column (Sephadex
G-25 superfine) preequilibrated with HEPES (20 mM, pH 7.4) containing 0.5 M NaCl. The
amount of A488 was determined spectrophotometrically at 495 nm and the PLL/PDL amount
by a TNBS assay. The molar ratio of PLL:A488 was 1:1.26 and of PDL:A488 1:1.15.
3.1.3 PEI particles
Unlabeled LPEI was dissolved in water, neutralized with HCl and gelfiltrated on a Sephadex
G-25 superfine column using 20 mM HEPES, 0.25 M NaCl, pH 7.4. For complex preparation
stock solutions of 1 µg/ml LPEI were prepared and provided by Katharina von Gersdorff and
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Carolin Fella (Prof. Wagner, LMU Munich). LPEI particles were prepared at a final DNA
concentration of 20 µg/ml by mixing plasmid DNA with LPEI, both diluted in HBG, at a molar
ratio of LPEI nitrogen to DNA phosphate (N/P) of 6.
For the experiments described in chapters 5 and 6 double-labeled LPEI particles were
used. These particles were synthesized as described above using A488-labeled LPEI instead
of unlabeled LPEI.
3.1.4 PEG-PEI particles
For the preparation of PEG (polyethyleneglycol) particles, a PEG-PEI conjugate, consisting
of 20 kDa PEG, coupled to 22 kDa LPEI, was synthesized and provided by Katharina von
Gersdorff and Carolin Fella (Prof. Wagner, LMU Munich) [116]. The PEG-PEI conjugate was
mixed with free LPEI at a molar PEG:LPEI ratio of 22:100. This solution was mixed with DNA at
an N/P ratio of 6 and a final DNA concentration of 200 µg/ml. The complexes were incubated
for 30 minutes at room temperature, snap-frozen in liquid nitrogen, and subsequently stored
at −80◦C until use. Before use, the complexes were allowed to stand for 30 minutes at room
temperature after thawing.
3.1.5 EGF-PEG-PEI particles
For EGF particles DNA was condensed by a mixture of three different conjugates. The first
conjugate (EGF-PEG-PEI) consisted of murine epidermal growth factor (EGF), 20 kDa poly-
ethyleneglycol (PEG) and branched polyethyleneimine. The second conjugate (PEG-PEI) con-
sisted of 20 kDa polyethyleneglycol and linear polyethyleneimine. Both conjugates were
synthesized and provided by Katharina von Gersdorff and Carolin Fella (Prof. Wagner, LMU
Munich) [116]. These conjugates were mixed with free LPEI at a molar EGF:PEG:PEI ratio of
13:22:100. This solution was then mixed with plasmid DNA at an N/P ratio of 6 and a final
DNA concentration of 200 µg/ml. In this way, the amount of PEI in the particles stems for 10%
from the EGF-PEG-PEI conjugate, for 12.5% from the PEG-PEI conjugate and for 77.5% from
free LPEI. The complexes were incubated for 30 minutes at room temperature, snap-frozen in
liquid nitrogen, and subsequently stored at −80◦C until use. Before use, the complexes were
allowed to stand for 30 minutes at room temperature after thawing.
3.1.6 PLL and PDL particles
For the preparation of PLL and PDL particles A488-labeled PLL or PDL was mixed with DNA
(consisting of 50% cy5-labeled DNA) at an N/P ratio of 2 and a final DNA concentration of
20 µg/ml. Complexes were allowed to stand for 30 minutes at room temperature and were
subsequently purified.
3.1.7 Polyplex purification
Polyplex purification was only performed for the experiments described in chapters 5 and 6.
The polyplexes were purified by size exclusion chromatography to remove unbound, labeled
polymer or DNA. For this purpose, a custom made free flow column was used. This method
was established by Boeckle et al. [118]. A standard-sized pasteur pipette was plugged with
glass wool and column material (Sephacryl S-200 HR, MW exclusion limit 250 kDa for
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globular proteins; Pharmacia Biotech, Uppsala, Sweden) and was filled into the glass pipette
leading to a final bed volume of 1.5 ml. The column material was equilibrated with HBG at
a pH of 7.4. Before loading the polyplexes onto the column, column material was precondi-
tioned with approximately 500 µg of the corresponding polymer-Alexa conjugate to reduce
posterior, unspecific binding of the polyplexes to the column material. Then the column was
rinsed with HBG and subsequently 600 µl of the polyplex solution were loaded onto the col-
umn. The amount of A488 and cy5 was determined by measuring the absorbance at 495
nm and 647 nm, respectively, using a Genesys 10-UV scanning spectrophotometer (Thermo
Spectronic, Rochester, USA). The final labeling ratio (molar ratio of A488:cy5) for LPEI, PLL,
and PDL particles was 5:1, 5.5:1 and 4:1, respectively.
3.2 Cell culture
Cell culture medium (DMEM/F12) and fetal bovine serum (FBS) were purchased from Invitro-
gen GmbH (Karlsruhe, Germany). HUH7 WT cells (JCRB 0403; Tokyo, Japan) were cultured
in DMEM/F12 (1:1) Glutamax-I medium supplemented with 10% FBS at 37◦C in 5% CO2 hu-
midified atmosphere. 48 hours before seeding the medium was changed to DMEM/F12 (1:1)
Glutamax-I with 5% B27 (Invitrogen, Karlsruhe, Germany) to reduce autofluorescence of the
cells.
HUH7 actin-GFP and tubulin-GFP (green fluorescent protein) expressing cell lines were
produced and provided by Katharina von Gersdorff (Prof. Wagner, LMU Munich) [116].
Rab5-GFP and Rab9-GFP expressing cell lines were produced and provided by Nadia Ruthardt
(Prof. Braüchle, LMU Munich).
Cells were seeded in DMEM/F12 (1:1) Glutamax-I medium with 5% B27 24 or 48 hours
before measurement in a density of 2.0 · 104 or 1.0 · 104 cells per well (1 cm2), respectively,
on collagen A-coated LabTek chambered cover glass (Nunc, Rochester, NY).
3.3 Widefield fluorescence microscopy
3.3.1 Widefield microscope
Widefield microscopy is based on uniform illumination of a micron-sized sample area [119].
To achieve uniform illumination, Koehler illumination is used. This principle was developed
by Koehler in 1893 [120] and is based on a separate illumination and image-forming pathway
with different conjugate planes to avoid focusing the light source in the sample [121].
The light source of a modern widefield microscope is mostly a laser or an arc lamp and
emits uniform light. This light passes through a collector, focusing it into the back focal plane
of the condensor. Most modern fluorescence microscopes are epi-fluorescence microscopes
in which the objective serves as a condensor [122]. This has the advantage that excitation
light in the detection channel is reduced, since only reflected excitation light will be detected.
From the objective a parallel light beam is transmitted, illuminating the sample. The fluo-
rescence from the sample is collected by the objective and is focused on the eye through the
eyepiece or onto the camera via a separate side exit of the microscope.
Fluorescent particles are visible on the camera as bright spots on a dark background.
Particles that are smaller in size than the excitation wavelength are not presented as points but
show a diffraction pattern called an Airy disk [121,123] consisting of a bright spot surrounded
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Figure 3.2: Jablonski diagram showing S0, S1 and T1 state. By absorption of a photon with
energy hν the molecule is excited from its S0 state into its S1 state. From here the molecule
can return back into the S0 state by emission of a photon. By intersystem crossing a transition
from the S1 state into the T1 state is possible with subsequent relaxation by means of phospho-
rescence.
by successive dark and bright concentric rings. The position of two adjacent particles can be
determined separately, i.e. the particles are just resolved, when the centers of their Airy disks
are separated by a distance equal to the radius of the Airy disk. The resolution of a setup –
the minimum distance between two particles allowing determination of each particle position
separately – is given by the Rayleigh criterion [121]:
d =
0.61λ
N.A.
(3.1)
in which d is the distance between the two particles, λ is the excitation wavelength, and N.A.
is the numerical aperture of the objective. A higher N.A. of the objective results in more
efficient fluorescence collection and thus in a shorter minimum distance of two objects that
can be resolved [124].
3.3.2 Fluorescence
The photophysics of most common fluorescent dyes can be described by a simple three level
Jablonski diagram consisting of S0, S1 and T1 state [119]. In figure 3.2 the different states
are depicted. For each electronic level several vibrational states are shown. Fluorophores
are usually excited to higher vibrational levels of S1 by absorption of a photon of excitation
energy hν (h is the Planck constant, ν is the optical frequency of the excitation light) emitted
by a lamp or laser. Via internal conversion the molecule relaxes to the lowest vibrational
level of S1 generally within 10−12 s or less [125, p.6]. From this state the excited molecule
can return to the ground state by emission of a photon. Fluorescence takes place on a time
scale of the order of 10−8 s [125]. The molecule is brought back to the initial ground state
by means of vibrational relaxation. Vibrational relaxation in both ground and excited state
causes a redshift of emission in comparison to absorption. The energy difference between
absorption and emission is called Stokes shift.
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Figure 3.3: Absorption (dotted line) and emission (solid line) spectra of Alexa Fluor 488
(green), cy3 (blue) and cy5 (red).
From the S1 state also transitions to the first triplet state are possible. This process is
called intersystem crossing and involves a change in spin angular momentum [126, p.552].
The triplet state lifetime is in the order of microseconds to seconds and the molecule can
relax by means of phosphorescence or by means of a bimolecular deactivation mechanism
(quenching).
Two different mechanisms of quenching exist: collisional quenching which is dependent
on diffusion of the quencher to the fluorophore and static quenching, in which case a complex
is formed between quencher and fluorophore [125, p.237]. A general kinetic expression for
a fluorescence quenching reaction is [127]:
A∗ + Q
k1


k−1
(A∗ · · ·Q) k2→ (A · · ·Q) + ∆
with A* the excited state of a fluorophore, (A∗ · · ·Q) an encounter complex and (A· · ·Q) is
some resulting complex in which excess energy has been dissipated as heat, ∆. k1 and k−1
are diffusional rate constants for the formation and breakdown of the encounter complex. k2
is the rate constant for the internal quenching process which may take place as electron spin
exchange, electron transfer or resonance energy transfer.
The absorption (dashed line) and emission (solid line) spectra of the dyes most frequently
used in this work are presented in figure 3.3. The spectrum of Alexa Fluor 488 is presented in
green. This dye was used to trace the endosomal escape of dextran and to label the polymer
component in the polyplexes. The spectrum of cy3 and cy5 is presented in blue and red
respectively. With these dyes DNA was labeled.
3.4 Experimental setup
The experimental setup is illustrated in figure 3.4. It is based on a Nikon Eclipse TE 200
microscope. In the following the excitation and detection pathway are discussed in detail.
3.4.1 Excitation pathway
Four different lasers were available for the excitation of different dyes. A 405 nm laser was
used to excite the photosensitizer, used for the experiments in chapters 5 and 6. It is a 50
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Figure 3.4: Experimental setup. Four different laser lines are available to excite the sample.
They are focused into the back focal plane via a fiber and two different lenses. The fluorescence
of the sample is collected by the objective and separated into two different channels. These
were projected onto two halves of the camera chip.
mW continuous wave Coherent diode laser. This laser was always used at an intensity of
0.34 W/cm2. A 488 nm Coherent Sapphire (optically pumped semiconductor) laser with a
maximum power of 20 mW was used to excite Alexa Fluor 488. For excitation of cy3 a 532
nm a Soliton continuous wave solid phase laser was available with an output of 5–200 mW.
The fourth laser was a Coherent Helium-Neon Laser with a maximal output of 35 mW at
632.8 nm. The intensity of the lasers varied extremely between 1 and 200 µW/cm2 depending
on the amount of dye. The laser lines were spatially overlayed via dichroic mirrors and
coupled into a multimode fiber (Amphenol, Wallingford, CT) to simplify alignment of the
different laser lines. A camera lens (AF Nikkor 50 mm, f = 45 mm) was used to parallelize
the light at the fibre exit. Through a rectangular field diaphragm the area of excitation was
confined to the area detected on the chip of the camera. The laser lines were focused in
the back focal plane of the microscope’s objective by a widefield lens ( f = 200 mm). Two
different objectives were used for the measurements: a Nikon PlanApo 60x/1.4 and a Nikon
PlanApo 100x/1.4. Both are oil immersion objectives.
3.4.2 Emission pathway
The fluorescence light of the sample is collected by the objective and passes through a
trichroic mirror. It is focused by a tube lens ( f = 160 mm). A telescope ( f1 = 150 mm,
f2 = 135 mm) reduces the image by a factor of 1.1. In the parallel beam path the fluores-
cence signal is splitted by means of a dichroic mirror, separating light under 640 nm from
light above 640 nm. Both emission beams are focused on one half of the camera chip. To
eliminate scattered excitation light a filter was placed in each beam path. For the emission
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path under 640 nm a bandpass filter was used (550/100 in case of GFP or Alexa Fluor 488
fluorescence and 575/80 in case of cy3). In the emission path above 640 nm another bandpass
filter was used (720/150). The detection unit was an EM-CCD (electron multiplying charged
coupled device) camera (Cascade 650; Roper Scientific, Tucson, AZ). The camera chip has
a size of 653 x 492 pixel. Since 1 pixel on the chip has a size of 7.4 µm x 7.4 µm, 1 pixel
on the chip corresponds to 85 nm in case of the 100x objective and 142 nm in case of the
60x objective. The overall magnification of the sample is given by the magnification of the
objective times the magnification in the detection pathway [128]. Thus, with a 100x objective
a magnification of 90x was obtained and a magnification of 54x was obtained when a 60x
objective was used.
3.5 Single particle tracking
The research on imaging of single molecule movement started in 1996 with a publication on
visualization of single phospholipids [129]. This arose much interest in imaging of single
fluorescent structures, especially in biological contexts, leading amongst other things to the
development of a technique called single particle tracking [130, 131]. In contrast to other
methods like fluorescence recovery after photobleaching (FRAP) or fluorescence correlation
spectroscopy (FCS), single particle tracking studies the properties of one single fluorescent
structure, be it a molecule, protein, virus or nonviral vector. Single particle tracking has
proved an excellent tool to provide new insights into the characteristics of macromolecules
and its surroundings [132–136]. Apart from a direct visualization of single biological struc-
tures, the movement of a particle can be analyzed in detail enabling accurate biological inter-
pretation.
To analyze the movement of a single particle, a trajectory has to be generated representing
this movement. To achieve this, the position of the particles for each video frame has to be
determined. The signal of single fluorescent particles appears on the detector as a spot. In
order to determine the x and y coordinates of this spot, different approaches can be used.
Direct fitting of a 2-dimensional Gaussian to the intensity profile of the spot is among the
most widely used methods [129, 137, 138], since the intensity distribution of a single spot is
well approximated by the gaussian equation:
f (x, y, A,w) = A · exp
(
− (x − x0)
2 + (y − y0)2
w2
)
. (3.2)
x0 and y0 are the x and y coordinates of the center of the curve, A is the amplitude of the
signal and w is the width of the gaussian curve.
After determining the particle coordinates for each frame, the displacement of the particle
between successive video frames can be determined. This can be calculated by means of the
nearest neighbor algorithm [139].
In this thesis fitting of the Gaussian and calculation of the particle displacement was
performed by means of a custom-build programm, developed by Kevin Braeckmans (Ghent
University, Belgium) and written in Matlab (The Mathworks, Natick, MA, USA).
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Figure 3.5: Three simulated MSD plots for different types of motion. The mean square dis-
placement 〈r2〉 is plotted versus ∆t. A linear plot indicates normal diffusion and is described by
〈r2〉 = 4D∆t (D = diffusion coefficient). A quadratic dependence of 〈r2〉 on t indicates directed
motion and is characterized by 〈r2〉 = v2∆t2 + 4D∆t. Asymptotic behavior for larger ∆t with
〈r2〉 = 〈r2c 〉[1 − A1e−4A2D∆t/〈r2c 〉] indicates confined diffusion.
3.5.1 Analysis of single particle trajectories
Single particle tracking provides information on the x− and y−coordinates of one particle
in time. From these data a 2-dimensional trajectory can be generated. This trajectory not
only gives information about the position of the particle in or at the cell, but also provides
information on the instantaneous velocity of the particle. More importantly, the trajectory can
be analyzed in order to get information on the diffusional behavior of the particle. Latter can
be characterized by means of a plot of the mean square displacement (MSD) 〈r2〉 versus the
time interval ∆t [130]. Several different models have been developed to analyze single MSD
curves [130, 140–146]. An example of an MSD-plot showing three different simulated curves
is given in figure 3.5. The following considerations are valid for 2-dimensional diffusion
only.
The linear plot indicates normal diffusion and can be characterized by
〈r2〉 = 4D∆t, (3.3)
where D is the diffusion coefficient.
Small deviations from normal diffusion can occur when diffusion takes place in the pres-
ence of random obstacles [141]. In this case the MSD curve is characterized by
〈r2〉 = 4D∆tα, (3.4)
with α < 1. This mode of motion is called anomalous diffusion.
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A quadratic dependence of 〈r2〉 on ∆t indicates directed motion overlayed by normal
diffusion and can be fitted by
〈r2〉 = v2∆t2 + 4D∆t (3.5)
where v represents the mean velocity of the particle.
Asymptotic behavior for larger ∆t with
〈r2〉 = 〈r2c 〉[1 − A1e−4A2D∆t/〈r
2
c 〉] (3.6)
indicates confined diffusion. In this case the particle is entrapped in a certain region out of
which escape is not possible.
√
〈r2c 〉 is the size of the confinement, the constants A1 and A2 are
determined by the confinement geometry. The asymptotic value of 〈r2c 〉 for large ∆t, which
is independent of the confinement geometry, was taken for the calculation of the size of the
confinement
√
〈r2c 〉. Note that confinement within a certain region can only be observed when
the observation time is large compared to the time between successive contacts of the particle
with the barrier. For short observation times, only normal or anomalous diffusion within the
confinement is observed.
3.6 Quenching
Quenching is a deactivation mechanism in which the excitation energy from one molecule is
transferred to another molecule that subsequently becomes excited. The molecules must be in
close proximity and one may act as a donor, the other as an acceptor. The acceptor molecule
may relax into the ground state by fluorescence or phosphorescence [147, p.276-297]
In this thesis, quenching of a fluorescent dye was used to distinguish between intra- and
extracellular particles. Trypan blue is a cell membrane impermeable dye that quenches the
fluorescence of cy3. Addition of trypan blue to cells incubated with cy3-labeled particles
results in fluorescence quenching of extracellular particles whereas internalized particles re-
main fluorescent. In this way extracellular and internalized particles can be distinguished.
In order to test the quenching effect, trypan blue was added to cy3-labeled particles on a
glass surface. For these particles an abrupt decrease in fluorescence intensity was observed
upon addition. This control was done for EGF, PEG and LPEI particles and a fluorescence
intensity decrease was observed for all three particles. The experiment was repeated with
cy3-labeled EGF particles on a cell. Cells were incubated with EGF particles and after 3 min-
utes 2.5 µl of a 0.4% trypan blue solution were pipetted into 400 µl medium in the experiment
chamber. Two images from an obtained video sequence are presented in figure 3.6a and fig-
ure 3.6b. Six particles are marked by boxes. Before addition of trypan blue the fluorescence
of the six particles was visible. After quenching, only particles 2 and 3 were visible and
have thus been internalized. Particles 1, 4, 5 and 6 were quenched and were therefore still
extracellular.
The fluorescence intensity of the boxed particles was plotted versus time in figure 3.6c.
Upon addition of trypan blue after 3 minutes, the fluorescence intensities of particles 1, 4, 5
and 6 decreases abruptly to background level. The fluorescence of particle 2 and 3 remains
constant. To separate the fluorescence of intra- and extracellular particles, a threshold was
set between the intensity of the background and the intensity of the non-quenched particles.
The horizontal black line indicates this threshold.
24
Q
(a) Before quenching (b) After quenching
(c) Fluorescence intensity
Figure 3.6: (a) and (b): Two selected frames of a video sequence before and after addition
of trypan blue to a cell incubated with EGF particles are shown. Six particles are marked
by boxes. Particles 2 and 3 were still visible after quenching and are therefore considered as
internalized. Particles 1, 4-6 were quenched and are therefore considered as extracellular. Scale
bar: 10 µm. The corresponding fluorescence intensity of the particles is plotted versus time in
(c). The quencher was added after 3 minutes. The fluorescence intensity of particles 2 and 3
remained constant whereas particles 1, 4-6 showed a decrease in fluorescence intensity to the
background level. The horizontal line indicates the threshold separating unquenched (intensity
above threshold) and quenched (intensity below threshold) particles after addition of trypan
blue.
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(a) Before quenching (b) After quenching
Figure 3.7: Two selected frames from a video sequence before and after addition of trypan
blue to a cell incubated with PEG particles are shown. The quencher was added 40 minutes
after particle incubation. Four particles are marked by boxes. The quenching of these particles
is inconclusive. The fluorescence of particle 1 and 4 did not disappear completely. Scale bar:
10 µm.
In contrast to the quenching of EGF particles, PEG particle quenching on cells was incon-
clusive. Upon quenching large particles lost only part of their fluorescence intensity. An
example of quenching of PEG particles in given in figure 3.7. Four particles are marked by
boxes. Particle 1 and 4 showed a reduced size after quenching, but the fluorescence intensity
(represented by the color map) remained the same. Particle 2 shows comparable behavior.
Only the fluorescence of particle 3 has disappeared after quenching.
This inconclusive behavior was representative for PEG particles and made it difficult to
state whether PEG particles were internalized or still on the cell membrane. The reduced
quenching was observed especially for larger particles. Since larger particles, in particular
PEG particles may be internalized by a mechanism different from smaller particles, an expla-
nation for the incomplete quenching may be found in the internalization mechanism. For PEG
particles no specific interactions with the cell membrane exist. Therefore, large PEG particles
may be internalized via unspecific phagocytosis, described in section 2.3.1. In this pathway,
the particle is engulfed by the cell membrane, driven by actin. The membrane completely
surrounds the particle after which the so-called phagosome pinches off from the membrane.
In case PEG particles are only partly quenched, the cell membrane could have surrounded the
particle and may shield part of the particle against the quencher. This would hinder trypan
blue to interact with the cy3-dye and causes a reduced quenching effect.
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4. Internalization dynamics of polyplexes
The plasma membrane is the first cellular barrier a gene vector encounters on its way to the
nucleus. Thus, in order to elucidate gene delivery by polyplexes, understanding the internal-
ization process is of great importance. As we have seen in section 2.2.2, PEI particles, upon
administration into the blood stream, especially end up in the lung [55], which may not be
the desired target tissue. To enhance uptake by a specific tissue, a receptor-specific ligand
can be coupled to the vector. In this way, the gene vector is mainly delivered to cells ex-
pressing the receptor corresponding to the ligand. In addition to this tissue-selective delivery
ligand-receptor binding activates the receptor-mediated endocytic pathway, increasing uptake
efficiency. Several studies have confirmed a positive effect of targeting ligands on gene ex-
pression [12] and internalization [13, 14] in vitro. However, the mechanism of enhancement
by means of receptor targeting has not yet been investigated in detail. In this context, single
particle tracking is a promising method to reveal the detailed dynamics and kinetics of the
internalization process of targeted versus untargeted gene vectors.
An example of a ligand is the epidermal growth factor (EGF) which targets the epidermal
growth factor receptor (EGFR) that is overexpressed on a wide range of tumors. In this chap-
ter the internalization dynamics of polyplexes with and without targeting ligand is compared.
The examined polyplexes consist of linear polyethyleneimine (LPEI) which provides the pos-
itive charge to condense the negatively charged DNA. The resulting positive charge of the
polyplex is shielded by polyethyleneglycol (PEG) reducing unspecific binding of polyplexes
to blood components and to cells (section 2.2.2). For targeting purposes EGF was added.
Polyplexes consisting of DNA condensed by LPEI and PEG only were used as control particles.
Additionally, the internalization dynamics of particles consisting of DNAand LPEI is analyzed.
The different particles are hereafter called EGF, PEG and LPEI particles, respectively.
By means of single particle tracking trajectories were generated representing the particles’
movement during the internalization process. In the first part of this chapter the morpho-
logical distinction of three different phases in the trajectories is discussed and a definition
for the phases is given. Following this, the time point of internalization and the percentage
of internalized particles for the three different polyplexes are determined. Lastly, the three
phases are analyzed in detail by mean square displacement and a biological interpretation of
the three phases is given.
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Figure 4.1: Interactions of the three different polyplexes with the cell membrane. LPEI particles
bind to the cell via electrostatical interactions, PEG particles show weak van der Waals and
hydrogen bond interaction and EGF particles bind to the EGF receptor.
4.1 Internalization of polyplexes
The examined polyplexes represent three different classes of interaction with the cell mem-
brane: electrostatical interaction, interaction via intermolecular forces and ligand-receptor
interaction. A schematic of these interactions is presented in figure 4.1. Positively charged
LPEI particles interact electrostatically with the negatively charged cell membrane. PEG parti-
cles show a weak interaction with the cell membrane via van der Waals forces and hydrogen
bonds [148]. Ligand-receptor interaction is represented by EGF particles that target the EGF
receptor. In this section an overview is given of the proposed internalization mechanisms of
the three particles.
The internalization pathway of PEI1 particles is based on electrostatical interactions between
the polyplex and components of the cell membrane. As a result of the excess of cationic
polymer, PEI polyplexes contain a positive net charge (a molar excess of positive charge).
The cellular membrane contains a negative net charge due to membrane-associated nega-
tively charged proteins such as proteoglycans [149]. There is strong evidence that sulfated
proteoglycans such as HSPG (heparan sulfate proteoglycan) serve as receptors for transfection
by cationic polyplexes like PEI particles [8–11]. Inhibition of the sulfation of proteoglycans
prevents stable binding and internalization of PEI coupled to quantum dots [10], suggesting a
major role of HSPGs in the internalization of PEI polyplexes.
Two major subfamilies of cell surface heparan sulfate proteoglycans are distinguished:
the syndecans and the glypicans. They differ in amino acid sequences of their core proteins
and mode of interaction with cell membranes. Glypicans are localized especially on the
extracellular side of the cell membrane whereas syndecans are transmembrane proteins that
can interact with the actin cytoskeleton. Kopatz et al. [150] suggested that syndecans play a
major role in polyplex internalization.
1 the following considerations are valid for linear as well as for branched PEI
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The precise internalization pathway and mechanism of HSPGs still remains to be eluci-
dated. It is known that HSPGs can take part in both clathrin- and caveolin-mediated inter-
nalization [151]. Also, binding of ligands to cell surface HSPGs can immobilize the proteo-
glycan in the plane of the membrane. For syndecans, ligand binding promotes dimeriza-
tion/oligomerization of bound ligand/syndecan complexes, which enhances the interaction
with the actin cytoskeleton [152].
The uptake pathway of PEI polyplexes has been examined in several studies by means of
inhibitors of the clathrin- or caveolin-mediated pathway [9, 153, 154]. Besides being partly
contradictory, the results were strongly dependent on cell type. Also, the pathway seems to
depend on the size of the complex [155]. For PEI particles immobilization and interaction
with the actin cytoskeleton, as observed for syndecan, was also observed [156].
Most recently, a detailed study examined the uptake of both PEI particles and HSPGs [9].
100% colocalization of PEI polyplexes and antibodies against HSPGs was found immediately
after internalization. Knock down of clathrin and caveolin by siRNA did not show significant
inhibition of internalization of both polyplexes and HSPGs. The uptake mechanism of both
polyplexes and HSPGs was dependent on dynamin and a high colocalization with the endo-
cytic protein flotillin was found. These findings suggest an internalization pathway for PEI
particles through binding with HSPGs independent on clathrin and caveolin, but dependent on
dynamin and possibly flotillin.
Due to their positive charge PEI particles have toxic effects in vivo as described in detail in
section 2.2.2. To reduce unwanted side effects, part of the PEI molecules can be substituted
by PEG-PEI molecules (see section 3.1.4). Since the electrically neutral PEG shielding reduces
binding to the cell membrane, adhesion of PEG particles to the cell is weak and PEG particles
may be internalized in a reduced amount compared to unshielded (PEI) or targeted (EGF)
particles. However, the PEG shielding is not complete. Studies on aggregation of PEG particles
have shown that particles consisting of DNA condensed with 25 and 10 kDa branched PEI
and covalently bound to 20 kDa PEG, were still able to interact with each other and form
aggregates [157]. This suggests that the PEG shielding does not completely cover all PEI
molecules of one particle. Therefore, some PEI molecules may still interact with the cell
membrane and bind to the HSPGs. Since in the experiments partly and completely shielded
particles cannot be distinguished, this introduces a bias towards partly shielded PEG particles.
Little is known about internalization of PEG-shielded particles. Luten et al. [158] com-
pared poly(DMAEA-co-BA)phosphazene-based polyplexes with and without PEG shield by
means of confocal microscopy and observed a reduced association and internalization in
the case of PEG-shielded complexes. In our experiments PEG-shielded particles are used as a
control to EGF particles to examine the influence of the EGF receptor targeting.
EGF particles consist of a PEI, a PEG-PEI and an EGF-PEG-PEI part (see section 3.1.5). The EGF
ligand serves to target the epidermal growth factor receptor (EGFR), which controls prolifera-
tion, differentiation and cell survival. The EGF receptor is overexpressed on a wide range of
solid tumors, including glioblastoma and hepatocellular carcinoma [159].
The EGFR is a 170 kDa transmembrane glycoprotein with a ligand-binding domain on
the extracellular site of the plasma membrane [160]. Before binding of a ligand, EGFR is
distributed evenly over the cell surface [68]. Upon binding, EGF receptors cluster into coated
pits [15, 67–69] followed by clathrin redistribution towards the cell periphery [70]. The
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latter observation, together with a publication on the colocalization of EGF with LDL (Low
Density Lipoprotein), a protein that is present on clathrin-coated vesicles, suggests that EGF
is internalized via the clathrin-coated pathway. However, clathrin-independent mechanisms
for the uptake of EGF have also been described [16,161,162]. Taken together, internalization
via both clathrin- and caveolin-dependent mechanisms seems likely [15, 16].
Internalization of ligand-bound EGFR is very fast. Haigler et al. described EGF-ferritin
localization in vesicles after 2.5 minutes [69] and Baulida reported the internalization of 125I-
EGF starting after 1.5 minutes [163].
4.2 Tracking of polyplexes
In order to clarify the difference between EGF-targeted and untargeted, shielded PEG particles,
2-dimensional trajectories of both particles representing the internalization process were gen-
erated. In addition LPEI particles without targeting and shielding component were measured.
For this purpose, the cells were treated as follows. HUH7 WT cells were seeded 24 or 48
hours before measurement in a density of 2.0 · 104 or 1.0 · 104 cells per well, respectively,
on collagen A-coated LabTek chambered cover glass. EGF, PEG and LPEI particles were pre-
pared as described in section 3.1. Before measuring, the medium of the cells was changed
to CO2-independent medium. Cells were placed on the microscope on a heated microscope
stage at 37◦C. To enable tracking of particles using our computer software particles had to
remain in the focal plane to avoid a change in fluorescence intensity or disappearance of the
particle. Therefore, cells had to be flat and preferentially the flat peripheral cytoplasm was
imaged. Particles were pipetted directly onto the cell under observation in order to get a clear
starting point of the attachment to the cell membrane. The DNA concentration on the cell
was unimportant, as in the measurements single particles were followed and no dependency
of the internalization on the DNA concentration was to be expected. The concentration was
adjusted such that individual particles could be detected and afterwards tracked. This was
achieved with a DNA concentration of 5.0 µg/ml for EGF and PEG particles and a concentra-
tion of 1.0 µg/ml for LPEI particles. Sometimes particles moved out of the focal plane due
to cell movement during the measurement or during internalization. As already discussed
above, tracking was hampered in these cases.
Taking into account the aforementioned conditions, the movement of the polyplexes on the
cell was imaged. The obtained sequences show that the particles quickly sedimented and
attached to the cell surface. After contact with the cell surface, EGF and LPEI complexes
were irreversibly docked onto the cell membrane due to their specific interactions. For PEG
particles a weaker attachment to the cell membrane was found than for EGF particles. By
resuspension of the medium in the chamber PEG particles were easily removed from the cell
surface, and undocking and docking events were even observed spontaneously with diffusion
between these events in the medium closely above the cell membrane.
4.2.1 Trajectories of EGF, PEG and LPEI polyplexes
Particle trajectories representing the movement during internalization were obtained by means
of single particle tracking (see section 3.5). More than 100 trajectories of single EGF, PEG and
LPEI particles were generated representing the particle movement up to 20 minutes after cell
30
T  
(a) EGF (b) PEG
(c) LPEI
Figure 4.2: Trajectories of the particles. The color changes with progressing time from red
through green to blue. (a) and (b) start directly after attachment of the polyplex to the cell
membrane. The trajectories represent: (a) an EGF particle tracked over a period of 4.5 minutes
with an acquisition time of 300 ms. The inset shows an enlargement of the first part of the
trajectory. Three morphologically distinguishable phases can be detected. Scale bar: 5 µm;
scale bar inset: 1 µm. (b) a PEG particle tracked over a period of 13.5 minutes (acquisition
time: 500 ms). Two distinguishable phases can be detected. Scale bar: 2 µm. (c) a LPEI
particle tracked over a period of 13.2 minutes (acquisition time: 500 ms). The trajectory starts
9.5 minutes after the attachment to the cell membrane. Two distinguishable phases can be
detected. Scale bar: 2 µm.
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attachment. In all trajectories, morphologically distinguishable phases could be observed. A
definition for these three phases will be presented at the end of the next section.
In figure 4.2 a representative trajectory is shown for all three particles. Figure 4.2a represents
a trajectory of an EGF particle recorded for 4.5 minutes starting with the attachment to the cell
membrane. The inset shows an enlargement of the first part of the trajectory. In this figure,
three different phases with morphologically distinguishable patterns can be detected. The
first phase, which lasts until t = 160 s, is characterized by steps that cannot be individually
distinguished, since the distance between subsequent steps is small. Also, a small directional
component is visible in the trajectory. The second phase is characterized by an increased
distance between subsequent steps and is accompanied by random motion of the particle.
The third phase starts at t = 240 s. Here, the distance between subsequent steps is largest
and steps are unidirectional. During the third phase alterations in the direction occur, these
are marked by arrowheads. For EGF particles, three morphologically different phases were
observed for the majority of the particles.
A trajectory of a PEG particle is presented in figure 4.2b. Although the PEG particle was
tracked more than three times as long as (13.5 minutes) the EGF particle, only two different
phases can be distinguished. The first phase consists of small steps within a small region
of the cell and lasts until t = 385 s. The transition to the next phase is represented by a
color change from green to blue. Within a few seconds the particle moves away from the
small area where it remained during the first 385 seconds and single steps of the particle
can be distinguished. The movement of the particle seems to go preferentially parallel to
one axis. This might be caused by structures in the cytosol that hinder movement of the
particle. This hypothesis will be discussed in detail in section 4.5.2. For PEG particles often
two morphologically different phases were observed.
A trajectory of a LPEI particle is presented in figure 4.2c. The trajectory starts 9.5 minutes
after pipetting the polyplexes onto the cells. The particle was tracked over a period of 13.2
minutes. In the beginning of the trajectory the particle moves in a circle that is completed
within 4 minutes. This kind of movement was observed often (also for PEG and EGF particles)
and may be explained by movement of the particle captured by filopodia as described in [164]
and [165]. Filopodia may attach to the particle and pull the particle towards the cell. After
582 seconds the movement of the particle changes to the next phase where individual steps
can be distinguished. As for PEG particles, often two morphologically different phases were
observed.
In short, for all three particles morphologically distinguishable phases were observed. In
order to sharply define the characteristics of these phases, velocity plots were generated.
4.2.2 Instantaneous velocity plots of EGF, PEG and LPEI polyplexes
The three phases observed in the trajectories are morphologically distinguishable by means
of their step sizes. Therefore, the distance traveled in 1 second was plotted versus time
in order to define the phases. The plots thus show instantaneous velocities. In figure 4.3
the instantaneous velocity plots corresponding to the trajectories shown in figure 4.2 are
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(a) EGF (b) PEG
(c) LPEI
Figure 4.3: Instantaneous velocity plots corresponding to the trajectories in figure 4.2. The
color coding matches that of figure 4.2. The plot represents the instantaneous velocities of
(a) an EGF particle. Three different phases can be distinguished based on the differences in
instantaneous velocity. (b) a PEG particle. Two different phases can be distinguished. (c) a LPEI
particle. Two different phases can be distinguished.
presented. Corresponding time points are marked with the same color.
In case of the EGF particle three different phases are clearly recognized in the plot. During
the first phase, instantaneous velocities around 0.25 µm/s are measured. A clear increase
in instantaneous velocity is observed for the second phase and another increase marks the
beginning of the third phase. The time points of the phase changes correspond well to the
morphological change in the trajectory: phase I was observed until t = 160 s, phase II until
t = 242 s followed by phase III.
In figure 4.3b the instantaneous velocities of the PEG particle are plotted. Here, the dis-
tinction between the first and second phase is even more pronounced. Phase I is observed
until t = 385 s, where the instantaneous velocity is around 0.25 µm/s. Phase II starts abruptly
at t = 385 s and instantaneous velocities of up to 1.45 µm/s are observed.
For the LPEI particle, the transition from phase I to phase II is observed at t = 582 s. The
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velocity of the first phase is in the same range as for EGF and PEG particles: velocities up to
0.3 µm/s are measured. The second phase is characterized by larger velocities up to 1.0 µm/s.
From these results it is clear that the different phases observed in the trajectories can be
defined by their instantaneous velocities. Remarkably, comparing the velocity plots of the
three particles, it becomes clear that for all three particles the first phase shows instantaneous
velocities in the same range. For the second phase the values are in the same range as well.
This implies that a definition of the different phases can be formulated applicable to all three
particles.
After generating velocity plots for more than 100 EGF, PEG and LPEI particles, the phases
were defined as follows: phase I contains no more than 5 successive steps with an instanta-
neous velocity above v = 0.5 µm/s. Phase II was defined as the intermediate period between
phase I and phase III and was heterogeneous in respect to instantaneous velocities. In most
cases, the average instantaneous velocities were above v = 0.5 µm/s. Phase III was distin-
guished from phase II by the criterion that it contains at least 16 successive steps in the same
direction.
Having defined the phases, we can concentrate on the main question of this chapter: what
is the difference between EGF particles and PEG particles? For PEG particles as well as for
EGF and LPEI particles different morphologically distinguishable phases were detected during
the internalization process. The instantaneous velocities of the different particles were in
the same range. A difference was only found in the duration of phase I. Typically, for EGF
particles, phase I lasted a few minutes, whereas for PEG particles and LPEI particles phase I
could last more than half an hour.
4.3 Time point of internalization
After defining the different phases during the internalization process the question arises dur-
ing which phase a particle is internalized into the cell. To determine the time point of inter-
nalization, a distinction must be made between extra- and intracellular particles. This was
achieved by performing quenching experiments with trypan blue. This dye is cell membrane
impermeable and quenches the fluorescence of cy3 as described in section 3.6. Addition of
trypan blue to cells incubated with cy3-labeled particles results in fluorescence quenching
of extracellular particles whereas internalized particles remain fluorescent. In this way extra-
cellular and internalized particles could be distinguished and latter could be tracked further.
Particles could be quenched only once and did not recover their fluorescence upon removal of
the quencher. Therefore, one quenching experiment represents one single-cell measurement.
For the quenching experiments, cells were treated similarly as described in section 4.2. To
induce quenching, 2.5 µl of a 0.4% trypan blue solution were pipetted into 400 µl medium in
the experiment chamber. Control experiments were performed and are described in section
3.6.
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(a) Trajectory (b) Instantaneous velocities
Figure 4.4: (a) Trajectories of two EGF particles showing phase I, tracked over a period of
192 s (blue) and 424 s (black) with an acquisition time of 500 ms. After 192 s trypan blue was
added to the cells (indicated by red arrows). One particle was quenched and the trajectory stops
(blue). The other particle remains visible and still shows phase I movement (black). Scale bar:
2 µm. (b) Instantaneous velocity plot of the trajectories presented in (a). Both particles show
the small instantaneous velocities characteristic for phase I.
To examine the time point of internalization in relation to the obtained trajectories, video
sequences were recorded with different time points of quenching starting with particle attach-
ment to the cell membrane. Trajectories were obtained as described before (section 3.5) and
the different phases were related to the quenching behavior. 40 trajectories were analyzed and
quenching of (part of the) polyplexes was only observed during phase I. Particles showing
phase II or phase III motion were not quenched.
In figure 4.4a an example is given of two EGF trajectories showing phase I movement
at the time point of quenching. After 192 seconds trypan blue was added, indicated by red
arrows. One particle was quenched: the trajectory stops at the moment of quencher addition
(blue). The second particle remains visible (black). This implies that the particle of which the
trajectory is shown in blue was not internalized at the moment of quencher addition, whereas
the second particle had already been taken up by the cell. The corresponding instantaneous
velocities are plotted in figure 4.4b. Both particles show the small instantaneous velocities
characteristic for phase I. These results show that during phase I particles can be either on the
cell membrane or internalized in the cell and imply that during phase I internalization occurs.
An example of a trajectory showing phase II movement during quencher addition is given
in figure 4.5a. The trajectory corresponds to a LPEI particle tracked for 16 minutes. At first
phase I movement is displayed. After 585 seconds, phase II movement starts. With the start of
phase II single steps in the trajectory become visible and in the corresponding instantaneous
velocity plot (figure 4.5b) an increase shows up. Trypan blue is added after 840 seconds
(in both figures indicated by a black arrow). The particle remains visible and has therefore
already been internalized.
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(a) Trajectory (b) Instantaneous velocities
Figure 4.5: (a) Trajectory of a LPEI particle tracked over a period of 964 s with an acquisition
time of 500 ms showing phase I and phase II. After 840 s, during phase II movement, trypan
blue was added to the cells (indicated by a black arrow). The particle was not quenched. Scale
bar: 2 µm. (b) Instantaneous velocity plot of the trajectory presented in (a). During phase I,
small instantaneous velocities are observed. The beginning of phase II is easily recognized by
a sudden increase in instantaneous velocity.
In summary, the quenching of most particles during phase I indicates that particles are still
accessible to trypan blue and attached to the extracellular side of the membrane. Sometimes
particles are not quenched during phase I. These particles obviously have been internalized by
the cell. During phase II and phase III no quenching was observed and these phases therefore
represent intracellular movement. Combining these results demonstrates that internalization
of the particles takes place during phase I only.
4.4 Internalization percentages
The main question of this chapter concerns the difference in the internalization process be-
tween receptor-targeted EGF particles and untargeted PEG particles. In addition, LPEI particles
without targeting and shielding component were examined. In section 4.2 we saw that differ-
ences between EGF particles and PEG particles are only observed in the duration of phase I.
In the last section we saw that during phase I internalization takes place. These findings raise
the question whether a difference is observed in the internalization kinetics of EGF and PEG
particles. This question can be answered by quenching of particles at different defined time
points and determination of the percentage of internalized particles.
Video sequences were recorded as described before (section 4.2). Trypan blue was added
to the cells at different time points (see section 4.3). By analysis of the video streams, as
described in section 3.6, the percentage of internalized particles per cell was determined at
various time points. Single frames before and after quenching were analyzed with respect
to the fluorescence intensity of all particles. By thresholding, the total number of particles
before and after quenching was counted as demonstrated in figure 3.6.
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(a) EGF (b) PEG
(c) LPEI
Figure 4.6: Percentage of internalized particles as determined by means of quenching experi-
ments at different time points. For EGF particles an extremely fast internalization is observed,
occurring on a time scale of minutes. PEG particles are internalized very slowly: after 80 min-
utes, less than 60% of the particles are internalized. LPEI particles are also internalized slowly.
The spread on the data is explained in the text.
Figure 4.6a shows the internalization kinetics of EGF particles. Internalization occurs within
a few minutes. Already 50% (median value) of the cell surface-associated particles were
internalized after 5 minutes, reaching 91% (median value) internalization after 10 minutes.
This extremely fast internalization is in good agreement with earlier observations for the
uptake kinetics of free EGF internalization. Haigler et al. described localization of EGF in
vesicles after 2.5 minutes [69] and a start of EGF internalization after 1.5 minutes was shown
by Baulida et al. [163].
In contrast, PEG particles showed a very slow internalization (figure 4.6b). After 80 min-
utes, less than 60% of the particles were internalized. As described in section 3.6, the quench-
ing of large PEG particles was not unambiguous. Often, only partial quenching was observed.
This may explain the large spread on the data. As mentioned in section 4.1 the shielding
of LPEI by PEG was not complete. Therefore partly shielded PEG particles may still bind to
the membrane by means of the unshielded LPEI molecules. This introduces a bias into the
measurements towards partly shielded PEG particles and thus the percentage of internalized
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PEG particles may actually be smaller.
For LPEI particles (figure 4.6c), the spread is even larger than observed for PEG particles.
After 25 minutes, the internalization percentage varied from 90% to less than 10%. This huge
spread can be explained by three different factors. The relevance of these factors increases
with time.
First, after pipetting the polyplexes onto the cell surface and subsequent attachment, a
medium change was performed. This medium change should produce a clear starting point
and prevent particles to settle down during the measurement which would distort the percent-
age of internalized particles at a defined point in time. Although the medium change may
have removed the majority of particles in the medium, a minority could still have been able
to settle down after diffusing in the medium for some time. These particles could not be
excluded from the measurements because due to computer memory constraints it was not
possible to follow the particles continuously during more than 20 minutes. Particles that
settled down onto the cell surface later could not be distinguished from particles that were
present on the membrane from the beginning. These particles would lead to a bias towards
extracellular particles.
Second, the amount of internalized particles is dependent on the region of the cell. Before
internalization, particles are attached and distributed evenly over the cell membrane. After
being internalized, particles are transported from the cell periphery towards the cell nucleus
thus concentrating internalized particles in this region. The percentage of internalized parti-
cles in a region containing the cell periphery is therefore lower than in a region close to the
nucleus. Since it is impossible to image all particles in one cell, the calculated percentage of
internalized particles is dependent on the focal plane of the microscope.
A third factor influencing the spread on the data is fusion of particle-containing endo-
somes after internalization. After internalization, particles are present in endosomes. Fusion
of these endosomes reduces the number of distinguishable particles inside the cell, since
several particles are present in the same endosome, but cannot be detected individually. Cal-
culation of the percentage of internalized particles will in this case yield too low a percentage.
Overall, these data show that EGF and PEG particles differ dramatically in their internalization
kinetics. Whereas 91% of the EGF particles is internalized after 10 minutes, less than 60%
PEG particles is internalized after 80 minutes. This can be explained by difference in duration
of phase I, observed in section 4.2. It brings us back to the main question of the chapter
and shows that targeting of a gene vector to a receptor markedly increases the efficiency of
internalization.
4.5 Analysis of the three different phases
Although in section 4.3 we saw that internalization takes place during phase I, the cellular
context of the different phases is still unclear. In this section the three different phases are
analyzed by means of mean square displacement (section 3.5.1), which enables a physical
description of the phases.
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Figure 4.7: Histogram of the instantaneous velocities during phase I generated from 10 EGF
particle trajectories. Phase I is characterized by a low instantaneous velocity typically below
v = 0.5 µm/s. The distribution contains a maximum at v = 0.1 µm/s.
4.5.1 Phase I
At the end of section 4.2 a definition was given for the three phases observed in section 4.2.1.
Phase I was defined as containing no more than 5 successive steps with an instantaneous
velocity above v = 0.5 µm/s. Over 100 EGF, PEG and LPEI trajectories were divided into
different phases, according to the aforementioned definition. For each phase a histogram was
produced depicting the number of frames with a specified instantaneous velocity within a
bin size of 0.05 µm/s. For phase I, the resulting distribution is presented in figure 4.7. It is
characterized by a narrow velocity profile with a maximum in the distribution at v = 0.1 µm/s.
Phase I was further analyzed by plotting the mean square displacement (MSD) 〈r2〉 versus time
∆t. (For a detailed description of mean square displacement see section 3.5.1.) In figure 4.8,
the MSD plots of phase I of 10 representative EGF trajectories are displayed. The MSD plot for
the trajectory shown in figure 4.2a is included and is distinguishable as a dotted curve. The
plots show a quadratic dependence of 〈r2〉 on ∆t, indicating directed motion. Fitting equation
3.5 to the data and averaging the obtained values for the 10 trajectories results in a mean drift
velocity vI = 0.015±0.003 µm/s and a mean diffusion coefficient DI = 4·10−4±4·10−4 µm2/s.
The large standard deviation is a result of the broad spread of the diffusion coefficients from
curve to curve in figure 4.8. For a single curve the diffusion coefficient can be calculated
much more accurately.
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Figure 4.8: MSD analysis of phase I motion. Phase I parts of trajectories were selected by
the criterion that they contain no more than 5 successive steps with an instantaneous velocity
above v = 0.5 µm/s. The MSD plots of 10 representative EGF trajectories are plotted including
the trajectory from figure 4.2a (dotted). The quadratic dependence of 〈r2〉 on ∆t indicates a
directed component.
Figure 4.9: Multiple particle tracking of five LPEI particles. Particles were tracked for 422
s with an acquisition time of 500 ms. The trajectories start immediately after the particles
attached to the cell surface. The color of the trajectory is shown as changing from red through
green to blue with progressing time. Correlated movement is illustrated by the simultaneous
bending of the trajectories. Scale bar: 4 µm.
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Figure 4.10: PEG particles on an actin-GFP expressing cell. The particles are represented in
red, the actin cytoskeleton is shown in green. The cell nucleus is located in the bottom right
corner of the image. Scale bar: 20 µm.
The question now arises what the origin of the directed movement during phase I is. An
indication as to what the answer might be can be found by looking at several particles on the
same cell simultaneously. The movement of particles on the same cell shows strong direc-
tional correlation, which can be demonstrated by tracking several polyplexes in proximate
vicinity. Five trajectories of particles in close vicinity are presented in figure 4.9. The color
of the trajectory changes with progressing time from red to blue for a total duration of 7 min-
utes. The trajectories show highly correlated motion patterns concerning both the form as
well as the temporal coincidence of directional changes. All trajectories show the small steps
characteristic for phase I. The directional and temporal correlation of the movement is illus-
trated by the simultaneous bending of the trajectories and indicates that phase I movement is
not caused by independent movement of single particles.
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As seen in the last paragraph there must be a common factor that influences the movement
of all particles. Additional experiments with actin-GFP expressing cells revealed that the
actin cytoskeleton played a major role in the movement during phase I. In the obtained video
sequences particles moved in correlation with the retrograde actin flow. This can easily be
recognized in a movie, of which one frame is shown in figure 4.10. The figure shows PEG
particles, represented in red, on an actin-GFP expressing cell, shown in green. Thin actin fibers
parallel to the cell edge and perpendicular to the radial stress fibers can be recognized. In the
original movie a correlation of the movement of these fibers with the particles’ movement
was observed. This suggests that the correlated particle movement during phase I is the result
of concerted movement of particles bound to the underlying cortical actin network through
transmembrane proteins.
In short, the observations of phase I amount to the following: it consists of instantaneous ve-
locities around v = 0.1 µm/s, the mean square displacement shows that a directed and a diffu-
sional component is present, and a correlation of neighboring particles and actin cytoskeleton
is observed. At the beginning of phase I particles are still on the cell membrane, but they are
internalized during phase I. The correlated movement of polyplexes and local actin structures
(figure 4.10) suggests that the directed movement of the polyplexes is attributed to the con-
stant movement of the retrograde actin flow with velocity vI = 0.015 ± 0.003 µm/s (for EGF
particles). A diffusional component is observed superimposed onto this flow with a diffusion
coefficient of DI = 4 · 10−4 ± 4 · 10−4 µm2/s which might represent the lateral diffusion of the
ligand-receptor complex in the cell membrane.
For EGF particles the directed component observed in the MSD plot can be interpreted as
follows. The EGF receptor is directly linked to the actin cytoskeleton via its cytoplasmic
site where an actin-binding sequence is present [166]. This results in a direct colocalization
of EGF particles with the actin cytoskeleton and the measured velocity is most probably the
velocity of the retrograde actin flow. In case of LPEI particles, Bausinger et al. [156] observed
a similar actin-mediated behavior with a velocity of v = 0.01 µm/s. A connection between
PEI particle-binding HSPGs and actin was suggested by Kopatz et al. [150]. Moreover, it was
shown for membrane glycoproteins that their movement is driven by the actin cytoskeleton
rather than by the lipid flow [167]. The velocity observed in our study is well in accordance
with velocities reported for endocytosed latex beads that showed an actin-mediated retrograde
flow with an average velocity of v = 0.016 µm/s and for gold particles bound to cell surface
glycoproteins [167, 168]. These values confirm the interaction of a polyplex-bound HSPG
with the actin cytoskeleton. The particles are thus transported by the flow of the underlying
cortical actin network after binding to cell surface receptors.
The diffusional component may be explained by diffusion of plasma membrane components
to which the particle is bound. In case of EGF particles the diffusion coefficient of DI =
4 · 10−4 ± 4 · 10−4 µm2/s is ten times lower than the diffusion of GFP-coupled EGF receptors
on the cell surface measured by Keating et al. [169]. The difference may be caused by the
particle binding to the receptor, which induces clustering of the EGF receptors (see section 4.1)
and may hinder the diffusion of the receptor on the cell membrane. The measured diffusion
coefficient is also in good agreement with Bausinger et al. [156] (D = 2 · 10−4 µm2/s) who
suggests that the diffusion represents the motion of the HSPGs in the membrane. This is
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Figure 4.11: Histogram of the instantaneous velocities during phase II generated from 13 EGF
particle trajectories. In phase II the instantaneous velocity is increased compared to phase I
with a maximum of the distribution at v = 0.2 µm/s.
supported by the diffusion coefficient of D ≈ 2 · 10−4 µm2/s for glycoprotein-bound gold
particles in the cell membrane reported by Sheetz et al. [167].
Finally, one last question remains to be answered. Why do we see phase I movement before
and after internalization? This can be explained by the high density of actin fibers directly
underlying the cell membrane. After "pinching off" from the membrane, the endocytic vesi-
cle is entrapped in the cortical actin network and its movement is still correlated with the
retrograde actin flow. Thus, the vesicle may need some time to escape this network.
4.5.2 Phase II
At the end of section 4.2 phase II was defined as the intermediate period between phase I and
phase III with instantaneous velocities in average above v = 0.5 µm/s. As for phase I, a dis-
tribution of the instantaneous velocities was obtained by analyzing different trajectories and
is presented in figure 4.11. Compared to phase I, the maximum of the distribution is shifted
towards a higher velocity, in this case at v = 0.2 µm/s, and the distribution is broadened.
The MSD analysis of phase II is presented in figure 4.12. The mean square displacement of
13 representative trajectories was plotted versus time. The MSD plots show normal diffusion
(Brownian motion) at the beginning for small ∆t and often asymptotic behavior for larger ∆t.
This asymptotic behavior indicates confined diffusion. The diameters of these confinements
were calculated by fitting equation 3.6 to the data. The obtained diameters range from 0.3 µm
up to 2.0 µm. As stated in section 3.5.1, the detection of confined diffusion requires a min-
imal duration of phase II. Therefore, not all MSD plots in figure 4.12 show the characteristic
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Figure 4.12: MSD analysis of phase II motion. Phase II parts of trajectories were defined as
following phase I and showing instantaneous velocities in average above v = 0.5 µm/s. 13
representative EGF trajectories were analyzed including the trajectory from figure 4.2a (dotted).
The plots mostly show asymptotic behavior for large ∆t indicating confined diffusion. The
linear dependence of 〈r2〉 on ∆t of the dotted line indicates normal diffusion.
asymptotic behavior. The dotted line for example, corresponding to the polyplex trajectory
shown in figure 4.2a, shows a linear dependence of 〈r2〉 on ∆t, indicating normal diffusion
with a diffusion coefficient of DII = 5.6 · 10−3 µm2/s.
Since the particles have already been internalized in phase I (section 4.3), the confined dif-
fusion results from local microenvironments in the cytoplasm experienced by the endosome
containing the particle. The network of cytoskeletal filaments, large macromolecules and
cytoplasmic organelles may act as local obstacles for free diffusion [170]. The obtained con-
finements of 0.3–2.0 µm in diameter are within the typical range for confinements in the
cytoplasm [171]. The "cage" sizes show a broad distribution as the size of the confinements
is strongly dependent on the location of the particle or vesicle within the cell. The restricted
diffusive mobility of larger structures such as vesicles enforces active transport in order to
bridge larger distances within the cell. Phase II can therefore be regarded as a lag phase after
internalization until a microtubule track for active transport is found.
A good example of barriers in the cytoplasm and therefore of confined diffusion is pre-
sented in figure 4.2b. Here, the confinement is clearly recognized. The endosome is moving
mainly parallel to one axis; in other directions the movement of the endosome is hindered,
probably by actin structures.
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Figure 4.13: Formation of an actin tail. 10 consecutive images from a movie are shown repre-
senting the colocalization of a PEG particle (red) and actin (green). At first a local increase in
the amount of actin is observed at the site of the particle, visible in the images as a yellow spot.
After 2.5 seconds an actin tail is formed (arrowhead) which presumably pushes the particle in
the direction of the cytosol. Scale bar: 2 µm.
Interestingly, when using actin-GFP expressing cells, sometimes colocalization of a particle
and an actin tail was observed. In figure 4.13 several consecutive images from a movie are
presented showing the formation of an actin tail. The particle is presented in red, actin is
presented in green. First, colocalization is observed between the particle and actin. After
2.5 seconds an actin tail is observed which by actin polymerization presumably pushes the
particle in the direction of the cytosol. The colocalization of actin and particle generally
lasted for 30 to 60 seconds and was only observed for a small proportion of the polyplexes.
Actin tails are a well-known mechanism for, e.g., intra- and intercellular transport of Listeria
in bacteria [172]. They have also been observed to facilitate the internalization of the SV40
virus [173] and they are known to play a role in the transport of endosomes towards the
cytosol [174, 175]. By means of a burst of actin polymerization, the endosome is propelled
in the direction away from the cell membrane.
4.5.3 Phase III
Phase III was defined as containing at least 16 successive steps in the same direction (section
4.2). As for phase I and II, a distribution of the instantaneous velocities was generated and
presented in the histogram in figure 4.14. A large increase in instantaneous velocity compared
to phase I and phase II is visible. Peak velocities up to 4 µm/s were detected and the peak
distribution is broader than in phase II.
Figure 4.15 presents 21 representative MSD plots of EGF particles for phase III including the
trajectory from figure 4.2a (dotted line). The plots show a quadratic dependence of 〈r2〉 on
∆t indicating directed motion. Fitting equation 3.5 to the data and averaging these values,
a mean velocity of vIII = 0.7 ± 0.4 µm/s was obtained and a mean diffusion coefficient
DIII = 0.1 ± 0.1 µm2/s.
45
I   
Figure 4.14: Histogram of the instantaneous velocities during phase III generated from 21
EGF particle trajectories. During phase III, rapid directed motion was detected with a broad
distribution reaching its maximum around v = 0.5 µm/s and peak velocities of v = 4 µm/s.
Figure 4.15: MSD analysis of phase III motion. Phase III parts of trajectories were selected by
the criterion that they contain at least 16 successive steps in the same direction. 21 MSD plots
of PEG trajectories including the one from figure 4.2a (dotted) are shown. The plots show a
quadratic dependence of 〈r2〉 on ∆t indicating directed motion.
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Typically, directed motion was observed for periods of 5 to 15 seconds and was frequently
alternated with phases of (confined) diffusion. Particles also stopped during directed motion,
changed their direction and moved back and forth on the same track before resuming their
original direction. Those alterations during directed motion resulted in an overall stop-and-
go motion of the particles. An example of this is visible in figure 4.2a. Directed motion
is first interrupted by diffusion (upper arrow head) and then by back-and-forth movement
(lower arrow head). Treatment of the cells with nocodazole, a microtubule-disrupting drug,
resulted in inhibition of phase III motion.
The interpretation of phase III motion is straightforward. Inhibition of the movement by
nocodazole indicates that particles are connected to the microtubule network during phase III.
The observed bidirectional transport showed stop-and-go motion characteristic for transport
along microtubules [176]. Active transport of LPEI particles along microtubules has been
shown before [156]. The mean velocity of vIII = 0.7 ± 0.4 µm/s observed in this study is
within the range for active transport by kinesin and dynein along microtubules [177]. Suh et
al. observed active transport of LPEI particles with a velocity of v = 0.2 µm/s [178], but did
not show the direct relation to transport on microtubules. Their average velocity for active
transport includes stop phases with v ≈ 0 and may therefore be reduced compared to the
actual transport velocity. The same holds for the study of Bausinger et al., who obtained an
average velocity of v = 0.19 µm/s. In contrast, in our calculations stop phases within the
trajectories were excluded. The resulting average velocity is therefore closer to the values
reported for active transport by kinesin and dynein. In short, these considerations give strong
evidence that phase III represents active transport along microtubules.
Typically, all three phases were observed for EGF, PEG as well as LPEI particles displaying
values for D and v in the same range. However, for many PEG and LPEI particles only one
or two phases were distinguishable during the observation time while the phase order always
remained unchanged. Differences between the particle types were only observed concerning
the duration of phase I. For EGF particles, the duration of phase I was considerably shorter,
lasting only a few minutes, whereas for PEG and LPEI particles it was sometimes observed for
more than one hour. For the particles analyzed, no difference was observed in the duration of
phase II (normal and confined diffusion) and phase III (directed motion).
4.6 Summary
In this chapter the internalization dynamics and kinetics of EGF, PEG and LPEI particles was
examined. Combining trajectories and instantaneous velocity plots, the internalization pro-
cess of polyplexes can be differentiated into three different phases. A biological interpretation
of these phases could be given after analysis by means of quenching experiments and mean
square displacement.
The first phase starts directly after attachment of the particle on the cell membrane. It
consists of a directed and a diffusional component. The directed component amounted to
vI = 0.015±0.003 µm/s. Since particles showed correlated movement and colocalization with
actin was observed, the directed component is most probably resulting from the movement
of the actin cytoskeleton to which the EGF receptor and HSPGs are bound. The diffusional
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component of DI = 4·10−4±4·10−4 µm2/s represents the motion of the receptor (EGFR in case
of EGF particles, HSPG for LPEI and probably PEG particles) on the cell surface. Quenching
experiments showed that during phase I internalization occurs.
Phase II starts with an increase in instantaneous velocity which may represent the escape
of the particle from the cortical actin network. This phase is characterized by normal and
later confined diffusion within the cytosol. The diffusion is limited by local macromolecules
or proteins in the cytosol. The confinements showed sizes of 0.3–2.0 µm in diameter.
An abrupt increase in instantaneous velocity and clear directionality characterizes the
beginning of phase III. The directed motion is alternated with short stop phases, representing
characteristic stop-and-go motion along microtubules. The directed motion during phase III
had a velocity of vIII = 0.7 ± 0.4 µm/s and was inhibited by addition of nocodazole.
A difference between the three particles was only observed in the duration of the first phase.
EGF particles showed phase I movement for some minutes, for PEG and LPEI particles this
phase could take more than one hour. This is related to the difference in internalization
percentages. The percentage of internalized EGF particles reached 50% within 5 minutes and
more than 90% within 10 minutes, whereas PEG and LPEI particles showed an extremely large
spread but rarely more than 80% internalization, even after 80 minutes.
These results show that targeting of polyplexes by means of a ligand leads to faster and more
efficient internalization as compared to untargeted particles.
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5. Photoinduced endosomal release of
polyplexes
In the last chapter we have seen how polyplexes overcome the barrier of the cellular mem-
brane. In this chapter we examine the next hurdle a vector encounters on its way to the
nucleus: the escape from the endosome. As we have seen already, polyplexes are internal-
ized by endocytosis and are therefore present in endosomes in the cell. Vectors that do not
escape from the endosome end up in lysosomes. Since in lysosomes the DNA is degraded
and is thus obviously not available for transcription in the nucleus, different techniques to
induce endosomal escape are under investigation. Examples to induce vector escape from en-
dosomes are functionalized vectors with pH-sensitive peptides or polymers that destabilize
the endosomal membrane at the low pH prevailing in late endosomes [7]. For this technique,
a change in vector synthesis is needed to implement the membrane-disrupting properties.
A vector-independent method developed by Berg et al. [179] employs photoactive com-
pounds for disruption of endosomal membranes. The mechanism by which photoactive
compounds induce endosomal escape is described in detail in section 2.5.2. In short, the
photoactive compound binds to the cell membrane and is endocytosed together with the
vector. Upon illumination with light of a defined wavelength, the photosensitizer becomes
activated and the cell membrane is damaged enabling escape of the vector. Studies using
fluorescent probes showed a change in distribution of the endosomal cargo within the cell
before and after the activation of a photosensitizer and suggest successful endosomal dam-
age and cargo release [179–181]. In addition, transfection studies with photoactive com-
pounds showed enhancement in gene expression most probably due to improved release of
the gene vector [17–19]. Photochemical release of gene vectors has also been implemented
in vivo [181–183].
The detailed mechanism of endosomal release induced by photoactive compounds has not yet
been unraveled. In this chapter, the endosomal release induced by activation of disulfonated
meso-tetraphenylporphine with the sulfonate groups on adjacent phenyl rings (TPPS2a) is im-
aged in real time using fluorescence microscopic methods. First the absorption and fluores-
cence characteristics of TPPS2a are determined. This provides information on the photophys-
ical processes of TPPS2a. Then, the visualization of endosomal release by means of micro-
scopic methods is confirmed by the endosomal release of a fluorescent fluid phase marker,
Alexa Fluor Dextran (AFD). Afterwards, the release of polyplexes is visualized.
Three different classes of polyplexes were examined. The first class consists of poly-
ethyleneimine (LPEI) polyplexes. As described in section 2.5.1 LPEI polyplexes have a high
buffering ability that prevents trafficking to lysosomes. Therefore, no degradation of the parti-
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Figure 5.1: Chemical structure of disulfonated meso-tetraphenylporphine with the sulfonate
groups on adjacent phenyl rings (TPPS2a). The inner (bold) structure represents the chemical
structure of a porphyrin.
cles before endosomal release is expected. The second class comprises polyplexes consisting
of DNA condensed by poly-L-lysine (PLL). Together with the third class (DNA condensed with
the stereoisomer poly-D-lysine (PDL)) it does not show buffering ability and both particles
end up in lysosomes. Whereas PLL is biodegradable by peptidases in the lysosome because
of its L-lysine residues, its stereoisomer PDL is nonbiodegradable.
By means of fluorescence widefield microscopy with high temporal resolution the pho-
toinduced endosomal release of all three particles was visualized. Release characteristics
such as mobility in the cytoplasm, degradation of the particles, and dissociation of polymer
and DNA are discussed and related to biodegradability, buffering capacity, and condensation
strength of the polymer.
5.1 Characterization of TPPS2a
The chemical structure of TPPS2a is shown in figure 5.1. TPPS2a belongs to the class of por-
phyrins. Porphyrins contain a large, highly delocalized pi system, resulting in a small en-
ergy gap between the highest occupied molecular orbital (HOMO) and the lowest unoccupied
molecular orbital (LUMO). Thus, absorption bands of porphyrins lie in the visible and near
UV regions of the spectrum [184, p.90]. Around 600 nm porphyrins typically show several
absorption bands, representing absorption from the S0 into the S1 state [185]. In the region
400–450 nm a broad absorption band (called Soret band) is present which represents absorp-
tion from the S0 into the S2 state. Thus, from the S0 state, transitions into the S1 and the
S2 state are possible. From the S2 state the molecule can show radiationless decay to the
S1 state, but also electron transfer from the S2 state was observed [185]. From the S1 state
fluorescence can occur, or through intersystem crossing (ISC) a transition from the S1 state to
the T1 state is possible.
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(a) Absorption spectrum
(b) Emission spectra
Figure 5.2: Absorption and emission spectra of TPPS2a dissolved in DMEM-F12 cell culture
medium. A maximum in absorption is observed at 418 nm. Emission spectra were recorded
with excitation at 405 nm, 417 nm and 488 nm. For excitation at 405 nm two weak fluores-
cence peaks are observed around 650 nm and 720 nm. Very weak fluorescence is observed for
excitation with 417 nm and for 488 nm excitation two clear peaks are distinguished at 651 nm
and 715 nm.
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In general, porphyrins show a high quantum yield for triplet state formation [186] and
thus long triplet lifetimes. The triplet state can be deactivated by phosphorescence, but in ad-
dition bimolecular deactivation mechanisms are possible involving the transfer of excitation
energy from one molecule to another. The latter process is called quenching.
Molecular oxygen (O2) has a triplet ground state 3Σ−g and a low energy gap separates
the triplet state from the lowest excited (singlet) state [187]. The long triplet lifetimes of
porphyrins, in combination with the low excitation energy of molecular oxygen give excel-
lent conditions for bimolecular deactivation processes of porphyrins and molecular oxygen,
which lead to the production of singlet oxygen. Tetraphenylporphine (TPP) is known to have
a high oxygen quenching constant of 1.42 · 109 dm3 mol−1 s−1 [186] and is correspondingly
a very efficient singlet oxygen generator. The mechanism of singlet oxygen generation by
quenching of triplet state sensitizers is described in detail in the publications of Schmidt et
al. and Mehrdad et al. [187, 188].
Figure 5.2a presents the absorption spectrum of TPPS2a. It was recorded on a Perkin Elmer
330 absorption spectrometer. The maximum of the Soret band is observed at 418 nm. Further
absorption bands are visible at 514 nm, 549 nm, 589 nm and 646 nm. As explained above, the
broad Soret band corresponds to absorption from the S0 state into the S2 state. The weaker
bands at lower energy represent absorption from the S0 into the S1 state.
Emission spectra of TPPS2a with excitation at 405 nm, 417 nm and 488 nm are presented in
figure 5.2b and were recorded on a FS900 fluorescence spectrometer (Edinburg Instruments).
All spectra were recorded under exactly the same conditions with the same scan speed and
step width. Excitation by 405 nm shows two small fluorescence peaks at 650 nm and 720
nm. Since 405 nm lies within the Soret band, TPPS2a is expected to be excited into the
S2 state. Apparently, at least part of the population falls back into the S1 state whereupon
fluorescence is observed. The region of this fluorescence is in agreement with measurements
on unsulfonated meso-tetraphenylporphyrine [189].
Excitation of TPPS2a by 417 nm shows very weak fluorescence around 650 nm. The reason
why this fluorescence band is smaller than the band due to excitation with 405 nm light is
not fully understood. The absorption at 417 nm most probably excites the molecule from its
S0 state into the S2 state. The fact that only weak fluorescence is visible, suggests that at this
excitation wavelength excited singlet TPPS2a is very efficiently converted to its triplet state
from which either phosphorescence occurs or quenching by molecular oxygen.
Excitation of TPPS2a at 488 nm excitation shows a clear peak at 651 nm and 715 nm.
Transition to the triplet state is probably not efficient in this case.
5.2 Endosomal release of AFD
In order to test whether endosomal release could be visualized in real time by microscopical
methods, the release of a fluid phase marker, Alexa Fluor Dextran (AFD), was studied prior
to endosomal release of polyplexes. Alexa Fluor Dextran is a 10 kDa dextran, a hydrophilic
polysaccharide, and is internalized into the cell by means of fluid phase endocytosis [190].
The dextran is labeled with the Alexa Fluor 488 dye, which has an absorption maximum at
495 nm and an emission maximum at 519 nm [191].
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Figure 5.3: Four selected frames of a video stream (acquisition time: 500 ms). The first
frame shows the cell with AFD-loaded endosomes before 405 nm illumination. Subsequent
images are shown 5.5 s, 8.5 s, and 11.5 s after the start of 405 nm illumination. A successive
disappearance of fluorescent endosomes was observed (arrows) after photosensitizer activation.
A minority of endosomes showed constant fluorescence intensity without detectable intensity
decrease (arrowhead). Scale bar: 5 µm.
HUH7 WT cells were seeded 48 hours before measurement in a density of 1.0 · 104 cells per
well, on a collagen A-coated LabTek chambered cover glass. After 24 hours, the medium
was changed in the dark to medium containing 0.025 µg/ml TPPS2a and 0.024 mg/ml AFD.
Control cells were incubated with medium containing only AFD. In this way, the endosomal
compartments were loaded with AFD, and TPPS2a was incorporated into the corresponding
membranes. Excitation of the photosensitizer with 405 nm light should damage preferentially
intracellular membranes with incorporated TPPS2a, in particular endosomes loaded with the
coincubated AFD. 12–16 hours later the cells were washed three times in the dark with CO2-
independent medium to remove residual TPPS2a. Since illumination of the cells should be
avoided, the samples were handled in aluminium foil before measurement and subsequently
placed on a heated microstage (37◦C) and imaged. For excitation of AFD, the 488 nm laser
line was used. In the following, the time printed on the images always represents the time
elapsed since the start of the 405 nm illumination.
The effect of photosensitizer activation on a cell preincubated with AFD and TPPS2a is pre-
sented in figure 5.3. The figure depicts four selected frames from a movie recorded with an
acquisition time of 500 ms. The bright, fluorescent spots represent endosomes filled with
AFD. The first frame shows endosomes before activation of the photosensitizer. Illumination
with 405 nm laser light for 5 seconds resulted in successive disappearance of the fluorescence
signal of single AFD-loaded endosomes visible in the following frames. The exact time point
of disappearance varied for individual endosomes. Interestingly, the fluorescent signal of
individual spots decreased in one sudden step (see arrows).
For a minority of AFD-loaded endosomal structures no decrease in fluorescence inten-
sity was observed, even after prolonged illumination with 405 nm light (see arrowhead).
Presumably, those structures did not incorporate TPPS2a in amounts sufficient for membrane
disruption.
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(a) Without photosensitizer
(b) With photosensitizer
Figure 5.4: Four selected frames from two different video streams (acquisition time: 70 ms).
Both video streams are recorded under exactly the same experimental conditions and camera
settings. Cells were incubated with AFD and without (a) or with (b) TPPS2a. The first image
shows the cell immediately after start of 405 nm illumination, the next image was taken 62
s afterwards. (a) No difference is observed in the amount of fluorescent endosomes. (b) The
TPPS2a-treated cell shows a strong reduction in the amount of fluorescent structures. Scale bar:
10 µm.
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To exclude the possibility of bleaching of the dye by laser light, control experiments with
cells incubated with photosensitizer-free medium were performed. For these cells different
behavior was detected. Upon illumination with 405 nm laser light no sudden disappearance of
fluorescent spots was observed. Under imaging conditions where a reduction in the amount of
fluorescent structures was observed for a TPPS2a-treated cell, fluorescent structures remained
visible in control cells.
In figure 5.4 an example of a cell incubated with photosensitizer free medium is com-
pared with a TPPS2a-treated cell. For both examples, two images from a video sequence are
presented. Both video sequences were recorded under exactly the same experimental con-
ditions and with the same camera settings. The images are taken directly at the beginning
of the 405 nm illumination period and 62 seconds after start of 405 nm illumination. No
decrease in the amount of fluorescent structures is observed for the cell incubated with photo-
sensitizer free medium (figure 5.4a), whereas the images representing the TPPS2a-treated cell
show a clear reduction in the amount of fluorescent structures. This confirms that the disap-
pearance of fluorescent spots is not due to bleaching of the Alexa dye by laser illumination,
as bleaching by the laser should be visible in both cases.
To further ensure that the sudden disappearance of fluorescent structures was indeed re-
stricted to the activation of photosensitizer and subsequent endosomal release the interaction
between TPPS2a and AFD was studied. A mixture of TPPS2a and AFD was imaged on a cover
slip under the same experimental conditions used for the aforementioned experiments. No
quenching effect or inactivation of the fluorescent AFD was observed.
In some cases, the disappearance of fluorescent spots after excitation of TPPS2a was accom-
panied by an increase in cytosolic fluorescence. In figure 5.5 the first and 50th frame (corre-
sponding to a temporal separation of 25 seconds) from a movie recorded with an acquisition
time of 500 ms with continuous 405 nm and 488 nm illumination are shown. At first, flu-
orescence is concentrated in bright spots representing endosomes. After 25 seconds, the
cytosol shows a faint fluorescence indicating the cell boundary as well as the nucleus. At
this time only few single fluorescent structures are visible. This indicates that the fluorescent
endosomal contents have been released into the cytosol.
A detailed analysis of the increase in cytosolic fluorescence is presented in figure 5.6. In
this figure the mean fluorescence intensity of a region in the cytosol of the cell periphery
without fluorescent structures (marked by a circle in figure 5.5) is plotted versus the 405 nm
illumination time. The fluorescence intensity was corrected for bleaching of the dye due to
488 nm laser illumination. The fluorescence intensity of a small spot was determined over
time until the start of 405 nm illumination. Thus, bleaching of this spot was only due to 488
nm illumination. These values formed the so-called baseline. Division of the fluorescence
intensity of the original spot by this baseline resulted in the presented values. These are
therefore relative values and the fluorescence intensity at the start of the measurement was
set to zero. The cytosolic fluorescence shows a steep increase between 6 and 15 seconds after
start of the 405 nm illumination. This increase correlates with the disappearance of several
bright spots.
The fluorescence increase of the cytosol was strongly dependent on the amount of AFD
internalized by the cell. In cells heavily loaded with AFD, the cell boundaries became visible
after excitation of TPPS2a as a result of the increase in cytoplasmic fluorescence. Charac-
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(a) Before endosomal release (b) After endosomal release
Figure 5.5: Two frames of a video stream recorded with an acquisition time of 500 ms. (a)
Cell with beginning of 405 nm illumination. The AFD fluorescence is concentrated in bright
spots representing endosomes. (b) After 25 s of 405 nm illumination the endosomal content
has been released resulting in a faint fluorescence of the cytosol. Thereby, the boundary of the
cell is visible. Scale bar: 5 µm. The circle indicates the region of interest analyzed in figure 5.6.
teristically, the nucleus did not show any increase in fluorescence intensity. For cells with
small amounts of internalized dye, an increase in fluorescence intensity of the cytosol was
not detected.
In order to obtain a detailed view of the endosomal release of AFD, the release process was
imaged at a higher temporal resolution. Analysis of movies recorded with 20 ms acquisition
time showed that the fluorescence of AFD did not disappear at once but dispersed around the
endosome (see figure 5.7a). Often, the dye release occurred asymmetrically. This suggests
rupture on one side of the endosome.
In figure 5.7b the fluorescence intensity of the endosome presented in figure 5.7a and
its surroundings is plotted versus 405 nm illumination time. The fluorescence intensity was
corrected for bleaching of the dye due to laser illumination as described before. A sharp
decrease in fluorescence intensity of the endosome after 12.9 seconds of illumination with
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Figure 5.6: The mean fluorescence intensity of a cytosolic region without fluorescent struc-
tures (marked with a white circle in figure 5.5) was plotted against illumination time. A steep
increase in intensity between 6 and 15 s represents the increase in cytosolic fluorescence and
corresponds to the release of AFD from endosomes.
405 nm light indicates the release of the cargo and correlates with a fluorescence increase
of the surrounding cytoplasm. Within 100 ms the fluorescence intensity of the endosome
decreases to 50% of the original value. In the same time span the surrounding cytoplasm
reaches maximum fluorescence intensity followed by a slower decrease to background level
within the next 500 ms in which the dye spreads out further into the cytosol. After the
respective maximum and drop in fluorescence, the fluorescence of the surroundings and the
former endosome remains constant.
In summary, these results show that endosomal release can successfully be visualized by
microscopic methods in real time. The photosensitizer was loaded into endosomes together
with the fluorescent dextran. Upon photosensitizer activation, the endosomal membrane was
damaged and the endosomal content was set free into the cytosol within 100 ms.
The rapid diffusion through the cytosol is in good agreement with studies on the diffusion
characteristics of FITC-dextran as performed by Arrio-Dupont et al. [170]. For dextrans with
a molecular weight of 95–150 kDa free diffusion in the cytosol was observed. In addition
dextrans smaller than 40 kDa were seen to enter the nucleus [170, 192]. In our case, the
nucleus was not stained by the Alexa dye, which may be due to the time point of observation.
In the aforementioned studies, dextrans were microinjected into the cytoplasm and the cells
were studied several hours afterwards to allow the cells to recover. In our case, the observa-
tion time was only 25 seconds. Nuclear entry of AFD may be observed when cells are imaged
some hours after inducing endosomal release.
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(a) AFD release
(b) Analysis of AFD release
Figure 5.7: (a) Endosomal release of AFD at a higher temporal resolution. The images show
one single endosome filled with AFD and correspond to eight frames of a movie recorded with
an acquisition time of 20 ms. The time stamp indicates the time after onset of 405 nm illu-
mination. The release of AFD occurs asymmetrically around the endosome. Scale bar: 2 µm.
(b) The mean intensity of the endosome shown in (a) and its surroundings was plotted versus
405 nm illumination time. The regions of interest are shown in the inset. Corresponding to
the release demonstrated in (a), the fluorescence intensity of the endosome shows a sharp de-
crease at 12.9 s. Simultaneously, the intensity of the immediate surroundings of the endosome
shows a sharp increase with a maximum after 80 ms, followed by a decrease due to diffusion
of the dye in the cytoplasm. After 13.46 s the intensity remains constant for both endosome
and surrounding.
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5.3 Endosomal release of polyplexes
After ensuring visualization of photoinduced endosomal release of AFD, the release dynamics
of polyplexes was investigated. Since LPEI, PLL and PDL polyplexes differ in their endosomal
buffering capacity, biodegradability and their binding strength to DNA, they are expected to
show distinct release dynamics.
LPEI is a nonbiodegradable polymer with protonatable amino groups with a pKa in the
range of 4 to 7. As we have seen in section 2.5.1 this characteristic leads to buffering of
endosomes such that lysosomal enzymes remain inactive and degradation of the gene vector
is impeded.
The cationic polymer PLL does not show the buffering ability as seen for LPEI [45, 193].
After endocytosis, endosomes containing PLL particles show a decrease in pH and maturation
to lysosomes takes place [193]. PLL is biodegradable because of its L-amino acid lysine.
Therefore, in principle peptidases and proteases in the lysosomes are able to degrade PLL and
consequently DNases are able to degrade DNA. However, studies with DNase I have shown that
the strong condensation of DNA by PLL protects polyplexes against degradation [194].
Like PLL, the D-amino acid stereoisomer PDL does not possess buffering abilities. The
intracellular pathway of PDL particles is therefore similar to that of PLL particles. In contrast
to PLL, PDL is nonbiodegradable, because of the D-amino acid residues. Nevertheless, this
characteristic does not influence the capability to protect DNA from enzymatic degradation
[195].
In order to image both components of the polymer/DNA particles simultaneously, the cationic
polymer was covalently labeled with Alexa Fluor 488 succinimidyl ester (A488) and DNA
with cy5. The labeled particles were purified to exclude free dye and polymer (see section
3.1.7). HUH7 WT cells were seeded 48 hours before measurement in a density of 1.0 ·104 cells
per well, on a collagen A-coated LabTek chambered cover glass. After 24 hours, the medium
was changed in the dark to medium containing 0.025 µg/ml TPPS2a and 0.1–1.0 µg/ml DNA de-
pending on the polymer. Control cells were incubated with medium containing only DNA. 12–
16 hours later the cells were washed in the dark three times with CO2-independent medium to
remove residual TPPS2a and subsequently placed on a heated microstage (37◦C) and imaged.
Since illumination of the cells should be avoided, the samples were handled in aluminium foil
before measurement. The focal plane of the microscope was found by weak excitation of the
cy5-labeled DNA at 647 nm, since the photosensitizer was least activated at this wavelength.
The 12–16 hours incubation of polyplexes and photosensitizer differs from earlier pub-
lished procedures [19]. In earlier publications cells were incubated overnight with photosen-
sitizer only prior to incubation with polyplexes for 4 hours in photosensitizer free medium.
The simultaneous, long incubation of polyplexes and photosensitizer as described above was
chosen to ensure that particles and photosensitizer were in the same cellular compartment
when observed under the microscope. To exclude adverse effects of this long incubation
in photosensitizer-containing medium on the transfection ability of polyplexes, transfection
experiments were carried out by Carolin Fella (Prof. E. Wagner, LMU, Munich) using both
procedures. Comparing the long overnight incubation of particles with the 4-hour incubation
on the following day, a higher transfection efficiency was observed for particles incubated
overnight. This indicates that the transfection ability of polyplexes is not impaired by longer
incubation times used for the microscopical observations.
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A direct influence of TPPS2a on A488 fluorescence as well as on particle integrity was ex-
cluded for all used polymers by addition of TPPS2a to A488-labeled LPEI, PLL and PDL parti-
cles on a cover slip. No quenching effect or inactivation of the fluorescence of the polymer
was observed.
In the following experiments the 405 nm laser line was used to induce photosensitizer
activation, the 488 nm laser line to excite the A488-labeled polymer and the 647 nm line
to excite the cy5-labeled DNA. The time printed on the images always represents the time
elapsed since the start of the 405 nm illumination. The duration of the 405 nm illumination
time is mentioned separately for each experiment.
5.3.1 LPEI
The first polyplexes to be characterized were LPEI/DNA particles. For these polyplexes, a
difference in fluorescence distribution within the endosomes between polymer and DNA com-
ponent was observed already before photosensitizer activation. Moreover, a different release
pattern was detected as demonstrated in figure 5.8a. The images represent four consecutive
frames of a movie recorded with an acquisition time of 500 ms and show a representative en-
dosome filled with LPEI/DNA particles. The fluorescence signal of both particle components,
LPEI and DNA, is presented in separate panels.
Before release, LPEI showed a homogeneous fluorescence distribution within the endo-
some. After activation of the photosensitizer, the release of LPEI was similar to AFD: the
fluorescence disappeared in one sudden step without persisting fluorescence above the back-
ground level in the endosomal region (figure 5.8a, lower panel). Furthermore, sometimes an
increase in cytosolic fluorescence throughout the whole cell was observed, depending on the
particle load of the cell. The fluorescence signal in the lower panel exclusively represents the
LPEI distribution, since free dye molecules were removed during the purification steps before
and during particle generation (described in section 3.1.7).
DNA in contrast showed an inhomogeneous fluorescence distribution within the endo-
somes (figure 5.8a upper panel). In large endosomes, several bright spots could be distin-
guished. Upon photosensitizer activation, the bright spots were released in a sudden "blow-
up"-like broadening of the DNA in different directions. This "blow-up" pattern reminded of
endosomes that burst under pressure. Afterwards, significant amounts of DNA remained vis-
ible in a confined area of a few micrometers in diameter around the damaged endosome.
Observations for two hours following release did not show any further movement of the re-
maining structures.
Analogously to AFD release, the release of DNA is analyzed in figure 5.8b. The fluorescence
intensity of the endosome and its surroundings was determined and plotted versus time. Cor-
rection for bleaching of the dye due to laser illumination was done by dividing the fluores-
cence intensities of endosome and surroundings by the fluorescence intensity of a background
region for each video frame. The values are therefore relative values and the fluorescence in-
tensity at the start of the measurement was set to one.
As observed for AFD, a drop in fluorescence intensity of the endosome was detected after
28 seconds of 405 nm light illumination. The intensity of the endosome decreased to 50%
within 4 seconds. Simultaneous with the decrease of the endosomal fluorescence intensity, an
increase in surrounding fluorescence was observed. In sharp contrast to the observations for
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(a) LPEI particle release
(b) Analysis of DNA release
Figure 5.8: (a) The images present four frames of a movie recorded with an acquisition time
of 500 ms and show one endosome filled with LPEI/DNA particles. The upper panel shows the
fluorescence intensity of DNA, the lower panel LPEI. After 28 s of 405 nm illumination, the
LPEI fluorescence disappears in one sudden step, whereas DNA fluorescence remains visible
in a confined area. Scale bar: 2 µm. (b) The mean DNA-cy5 fluorescence intensity of the
endosome shown in (a) and its surroundings (see inset) was plotted versus 405 nm illumination
time. After 28 s, a decrease in endosome intensity and an increase in surrounding intensity was
observed. Both intensities reach a constant level after 33 s.
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AFD, the fluorescence intensity of the surroundings remained at a constant level and did not
decrease to the background value. This shows that after membrane rupture, the DNA disperses
in a sudden burst around the endosomal region but remains immobile afterwards. Therefore
the intensity of the surroundings does not drop back to background level as observed for AFD,
which diffused into the cytoplasm.
In short, we observed the following differences between the release patterns of DNA and LPEI:
first, the heterogeneity (DNA) versus the homogeneity (LPEI) of the fluorescence within the
endosome; second, the particulate versus homogeneous spread into the cytosol after release;
third, the confined reminiscence of the DNA fluorescence versus spread of LPEI fluorescence
throughout the whole cell; and fourth, the different time scales of endosomal fluorescence
decrease.
From these differences, the release of LPEI/DNA particles can be interpreted as follows.
After endosomal rupture, diffusion of LPEI through the cytosol is observed resulting in de-
creasing fluorescence intensity of the former endosome and an increase in cytosolic fluores-
cence. LPEI has a molecular weight of 22 kDa allowing diffusion in the cytoplasm [171,192].
Plasmid DNA in contrast cannot diffuse in the cytosol due to its large size [107,108]. Its diffu-
sion in the cytoplasm is hindered by various cellular structures and DNA is therefore largely
immobile. This explains the observed differences in the diffusion behavior between LPEI and
DNA.
The fact that this difference was observed implies that LPEI and DNA are dissociated to
a large extent during endosomal release. Decondensation of LPEI and DNA in the cytoplasm
was shown by Itaka et al. [196]. Dissociation in the cytoplasm may be induced by RNA
[197]. However, this process takes place on a larger time scale than the rapid release of LPEI
observed here. This suggests that the particles in the endosome have to be in a decondensed
state already before rupture of the endosomal membrane. The inhomogeneous pattern of the
DNA versus the homogeneous distribution of LPEI in the intact endosomes supports (partial)
decondensation of the polyplexes in the endosome.
The release of DNA was observed as a fast broadening of fluorescent structures that were
immobile afterwards. The fast movement of the nondiffusible DNA for a very short moment
may be induced by pressure. An eventual pressure in the endosomes may be explained by the
"proton sponge" effect of LPEI (section 2.5.1). The buffering capacity and reduced acidifica-
tion is accompanied by an increased chloride accumulation resulting in osmotic swelling of
the endosomes [45]. Damaging the membrane of an endosome under pressure would there-
fore lead to a burst that is observed as a fast broadening of the nondiffusible DNA. The "proton
sponge" effect also inhibits progression to lysosomes by buffering the pH of endosomes [198].
Therefore the DNA is protected against degradation even in case LPEI and DNA decondensate
in the endosome before release. This is in agreement with the observation of nondiffusible
and therefore intact plasmid DNA after endosomal release.
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To summarize, LPEI/DNA particles seem to be dissociated already before endosomal release.
They are present in endosomes, since no lysosomal degradation of the DNA is observed. Upon
release, LPEI diffuses freely through the cytoplasm due to its small size. DNA is released out
of the endosome under pressure and is afterwards immobile in the cytoplasm.
5.3.2 PLL
For LPEI and DNA no colocalization was found after endosomal release which implies that
LPEI particles are dissociated during endosomal release. To determine whether the release
behavior of DNA and polymer was dependent on binding affinity to and the characteristics of
the cationic polymer, a polymer with stronger DNA binding properties was used. In previous
studies it was shown that the polymer poly-L-lysine (PLL) has a much higher affinity for DNA
than LPEI resulting in stronger particle condensation [196]. It was shown that the condensed
state of the PLL particles was maintained in the cytoplasm and thus no dissociation took place.
Therefore, colocalization of PLL and DNA after endosomal release is expected.
For PLL/DNA particles, polymer and DNA showed comparable release patterns. According to
the release dynamics, two endosomal populations were classified. These two populations are
depicted in figure 5.9. Two images from a video sequence are presented directly after the
start of the 405 nm illumination and at t = 110.5 s. The fluorescence signal of DNA and PLL
is presented in different channels.
A homogeneous fluorescence distribution within the endosome was characteristic for
PLL as well as for DNA before photosensitizer activation. In sharp contrast to the release
of LPEI/DNA particles, all endosomes showed simultaneous and similar endosomal release
of both PLL and DNA. The majority of endosomes released their contents completely in one
sudden step without visible remaining fluorescence. For a small fraction of endosomes, illu-
mination with 405 nm only led to a small decrease in fluorescence intensity for PLL as well
as DNA. In figure 5.9 three endosomes are visible showing this behavior (arrowheads).
In figure 5.10 and figure 5.11 an example of these differing populations of endosomes is
presented. Figure 5.10 shows three consecutive frames from a movie recorded with 500 ms
acquisition time. The fluorescence intensity of both particle components of the endosome
marked with an arrow simultaneously decreased in a sudden step after illumination with 405
nm laser light. Only slight fluorescence remained in the endosomal region for both compo-
nents (figure 5.10, arrow). The second endosome, marked with an arrowhead, shows endoso-
mal release at a later time point. The decrease in endosomal fluorescence was accompanied
by a slight increase in cytosolic fluorescence intensity of PLL.
In figure 5.11 one endosome is presented which shows only a small decrease in fluores-
cence intensity for PLL as well as DNA after illumination with 405 nm light. The release is
indicated by the change in diameter of the fluorescence signal between frame two and three.
Particles with only a small decrease in intensity after release were comparably bright even
after prolonged illumination. The spots persisted at the location of the original endosome
without any movement.
As mentioned at the beginning of this section, PLL/DNA particles were expected to show
colocalized endosomal release, because of the higher DNA binding affinity. This was indeed
observed. For the majority of endosomes, a rapid diffusion of PLL as well as DNA was noticed
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(a) DNA
(b) PLL
Figure 5.9: Image at the start of 405 nm illumination (left) and after 110.5 s (right) with an
acquisition time of 500 ms. The 405 nm illumination period lasted 10 s. In (a) the distribution
of DNA-related fluorescence in a cell is shown. In (b) the fluorescence of PLL is presented. The
overwhelming majority of endosomes disappears completely after photosensitizer activation.
Three endosomes show only a small decrease in fluorescence intensity (arrowheads). Scale
bar: 10 µm.
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Figure 5.10: The images show frames from a movie recorded with an acquisition time of
500 ms. The cells were illuminated with 405 nm laser light for 5.5 s. The images show two
endosomes in three subsequent frames 47.5 s after start of 405 nm illumination. The upper
panel represents DNA fluorescence, the lower panel PLL fluorescence. In one endosome, the
fluorescence intensity of both DNA and PLL decreased in one sudden step (arrow) and little
fluorescence remained in the endosomal region whereas the second endosome (arrowhead) did
not release its content in the presented time interval. Scale bar: 2 µm.
Figure 5.11: The images show frames from a movie recorded with an acquisition time of 500
ms. The cells were illuminated with 405 nm laser light for 5.5 s. The images present four
subsequent frames of a movie showing one endosome filled with PLL/DNA particles. The upper
panel represents DNA fluorescence, the lower panel PLL fluorescence. The first frame shows
the endosome 50.5 s after the start of 405 nm illumination. The fluorescence intensity of both
DNA and PLL decreased only slightly and a bright spot remained visible even after prolonged
illumination with 405 nm laser light. Scale bar: 2 µm.
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upon photosensitizer activation. Simultaneous and similar release behavior was seen as well
for the small fraction of endosomes that showed only a small decrease in intensity. The
fact that a cytosolic increase in fluorescence was observed for PLL but not for DNA may be
explained by the different labeling ratios of both components. Since the molar ratio of Alexa
dye:cy5 dye was 5.5:1, PLL may have remained visible after endosomal release, whereas DNA
could not be detected further.
The observation that DNA diffuses rapidly away from the endosome implies that it is
degraded into smaller fragments before endosomal release is induced. The cellular compart-
ment for degradation in the endocytic pathway is the lysosome, therefore PLL/DNA particles
are most probably transported to lysosomes. This is confirmed by Akinc et al. [193] demon-
strating that the PLL/DNA particles are present in compartments with low pH and thus no
"proton sponge" effect was observed [45].
Now the question arises whether the colocalized endosomal release of DNA and PLL
proves that the particles are still condensed in the cytoplasm. When in condensed form, PLL
protects DNA from degradation by DNAse I, a DNA digesting enzyme [194]. However, DNA
showed rapid diffusion upon endosomal release implying degradation of DNA. Therefore, par-
ticles may be dissociated before endosomal release takes place. The protection of DNA by
PLL may have been lost during the 12 hours incubation period and degradation of PLL and
DNA may induce dissociation of the complexes.
A small population of endosomes filled with PLL/DNA particles showed only a modest
decrease in fluorescence intensity after activation of the photosensitizer. This suggests that
the polyplexes are still partly intact, probably due to the strong condensation of DNA by
PLL. Upon endosomal disruption the condensed particles are too large to diffuse through the
cytoplasm. These particles may still be in late endosomes where little degradation occurs.
In short, two populations of PLL/DNA particles can be distinguished. The largest population
is transported to lysosomes where degradation of PLL and DNA takes place. Upon photosen-
sitizer activation, both components diffuse freely through the cytosol. A small population of
particles may still be in late endosomes where little degradation occurs. It consists partly of
intact particles that are too large to diffuse through the cytoplasm.
5.3.3 PDL
Up to this point, release of intact DNA was observed when DNA was condensed with a non-
biodegradable polymer with buffering ability. DNA degradation occurred for biodegradable
particles without buffering capacity. To relate the degradation of DNA to biodegradability,
poly-D-lysine (PDL) was used as a condensing polymer. PDL is the D-amino acid isomer of
PLL and is also able to condensate DNA [51]. Just as PLL it is not able to buffer the pH of
endosomes. Due to its D-amino acid residues it is not accessible to enzymatic digestion in
the lysosome.
The release of PDL/DNA particles is presented in figure 5.12. Four frames from a video se-
quence recorded with an acquisition time of 500 ms are shown. The first frame shows the
cell immediately after the end of the 405 nm illumination period (13.5 s). The fluorescence
signal of DNA and PDL is separated in different panels. Upon activation of the photosensitizer,
most endosomes containing PDL/DNA particles did not show a clear and sudden decrease in
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Figure 5.12: Four images from a video sequence recorded with an acquisition time of 500 ms
are shown. The first frame shows the cell immediately after the 405 nm illumination time (13.5
s). Following frames are taken 38 s, 114 s and 338 s after the start of 405 nm illumination. The
upper panel represents DNA fluorescence, the lower panel PDL fluorescence. Most particles do
not show a clear decrease in intensity. Some particles show a decrease in intensity in the DNA
fluorescence signal but no decrease in PDL fluorescence (boxed particle). Scale bar: 10 µm.
intensity. As this could also be caused by a lack of photosensitizer in the endosomes, the ef-
ficacy of endosomal release was verified in control samples with the same amount of TPPS2a
and LPEI/DNA particles under the same imaging conditions.
A second, small fraction of PDL/DNA particle-loaded endosomes was observed that showed
a slight decrease in intensity of the PDL signal and a stronger decrease in intensity of the DNA
signal. In figure 5.12 these are marked by boxes.
Since PDL particles do not show buffering ability, the two observed populations of PDL par-
ticles are expected to be in lysosomes. The largest population of lysosomes did not show a
clear decrease in intensity. For these particles, PDL has successfully protected the DNA from
degradation. Particles remain intact and therefore immobile in the cytoplasm upon photosen-
sitizer activation.
For a small population of lysosomes, a modest decrease in the intensity of the DNA signal
was observed. In these lysosomes, nucleases may have been able to cleave a certain amount
of DNA during the long incubation period. Although it was shown that PLL and PDL can protect
DNA from degradation in experiments with 30 minutes incubation in crude cell lysates [195],
our results with 12 hours incubation suggest that DNA is not fully protected against lysosomal
degradation on longer time scales. Overall, the nonbiodegradable PDL protects the DNA from
degradation, although not as efficiently as observed for LPEI.
67
P    
Taken together, two populations of PDL/DNA particles can be distinguished. The largest pop-
ulation is presumably transported to lysosomes but degradation of DNA is hindered by PDL.
Upon photosensitizer activation, intact particles remain immobile in the cytosol. A small pop-
ulation of particles may be partly degraded and release of DNA into the cytosol is observed.
5.4 Summary
In this study we visualized endosomal release of polyplexes induced by photosensitizer ac-
tivation. The release of a fluid phase marker provided information on the efficacy of pho-
toinduced endosomal release and on the time scale of release. By comparing the endosomal
release of three different classes of polyplexes, release characteristics like mobility in the cy-
toplasm, degradation of the particles and dissociation of polymer and DNA were investigated.
The results demonstrate that the characteristics of the cationic polymer used to condensate
DNA significantly influence the release behavior of the polyplexes.
Experiments with a fluorescently labeled dextran showed successful loading of endosomes
with photosensitizer and AFD. Upon photosensitizer activation, the endosomal membrane was
damaged and the endosomal content was set free into the cytosol within 100 ms. AFD rapidly
diffused through the cytosol without staining the nucleus within the observation period.
For the release of the cationic polymers, the following behavior was observed. Upon release,
the intact (since nonbiodegradable) LPEI diffused quickly away from the original endosome
and was spread throughout the cytosol, which can be explained by the small size of the poly-
mer. On the time scales of observation, no diffusion of LPEI into the nucleus was observed.
PLL has a higher binding affinity to DNA than LPEI. Therefore, PLL was expected to protect
the DNA more efficiently than LPEI and thus to prevent dissociation of the polyplex. In this
case, the intact particles would remain immobile in the cytoplasm. Nonetheless the release
behavior of PLL was similar to LPEI. PLL diffused from the endosome without any remaining
structures on the site of the endosome and in rare cases an increase in cytosolic background
indicated diffusion throughout the cytosol. PLL is biodegradable and may therefore be de-
graded in the lysosome. Then, PLL is able to freely diffuse from the endosome throughout the
cytosol upon photosensitizer activation.
For PDL, almost no release was observed upon photosensitizer activation. PDL condenses
DNA in the same way as PLL. In contrast to the condensation of LPEI, the strong condensa-
tion of PDL protects DNA against degradation. PDL itself is not biodegradable and therefore
PDL/DNA particles remain intact. Thus, after photosensitizer activation particles remain im-
mobile in the cytoplasm.
The release of DNA showed more distinguishable patterns. For LPEI/DNA particles, release of
intact DNA was detected. The fact that LPEI/DNA particles remain in endosomes instead of
lysosomes may play a major role in the conservation of DNA. Since LPEI/DNA particles have
buffering ability which leads to reduced acidification DNA is prevented from degradation by
lysosomal enzymes. The relatively weak binding affinity of LPEI to DNA, compared to PLL
and PDL, may be lost within the endosomes already.
For PLL/DNA particles, fast release of both polymer and DNA was observed. Since PLL is
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biodegradable and does not show a proton sponge effect, it may be degraded in the lysosome.
This induces degradation of DNA and probably dissociation of the polyplex.
PDL/DNA particles remain largely intact in lysosomes due to the nonbiodegradability of
PDL. Therefore, DNA remains largely within the endosome upon photosensitizer activation.
Some DNA was released, possibly due to some lysosomal activity as a consequence of the
long incubation time of 12 hours.
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6. Cellular effects of photoinduced endosomal
release
In the last chapter we saw that activation of TPPS2a results in cargo release from endosomes.
TPPS2a is excited into a singlet state and subsequently falls back into a triplet state. This triplet
state is quenched by molecular oxygen whereupon singlet oxygen is generated. Damage of
macromolecules in the endosomal membrane by singlet oxygen then leads to endosomal
escape.
Apart from increasing endosomal release of gene vectors, the generation of singlet oxy-
gen by photoactivation of porphyrins is known to have side effects. Singlet oxygen is a highly
reactive species with a lifetime of maximal 4 µs in H2O [105] and a diffusion radius of 50
nm [106]. It easily oxidizes organic macromolecules like membrane lipids, proteins, amino
acids, DNA and RNA [20, 199] that are in close proximity. Generation of large amounts of
singlet oxygen in the cell leads to damage of cell membranes, mitochondria, lysosomes and
nuclei and eventually to apoptosis of cells [200]. These harmful side effects are exploited
by photodynamic therapy, a method to reduce cancer growth. In this method, photosensitive
compounds (often porphyrins) are intravenously administered to the body and accumulate in
tumor tissue. Upon photosensitizer activation, singlet oxygen is produced and reacts with
intracellular targets which eventually leads to tumor necrosis [200].
In addition to singlet oxygen-related side effects, a direct influence of porphyrins on
cellular compartments was observed. Porphyrins interact with the microtubule cytoskeleton
by inhibition of microtubule assembly [201], most probably by binding to tubulin [202].
In this chapter the influence of TPPS2a on different compartments of the cell is examined. First,
the interaction of TPPS2a with microtubules and actin cytoskeleton is studied. Second, the
effect of photoactivation on early and late endosomes is demonstrated. Finally, an influence
on endosomal motion is observed immediately after start of photosensitizer activation.
6.1 Microtubules and actin
It has been demonstrated earlier that porphyrins have a toxic effect on the cytoskeleton by
inhibition of microtubule assembly [201]. Porphyrins bind to tubulin heterodimers [202] and
a decrease in the amount of microtubules was found upon incubation of cells with tetra(4-
sulfonatophenyl)porphine (TPPS4) [203]. Nevertheless, visualization of microtubule damage
by means of high resolution microscopy has not yet been performed. This motivated us to
perform highly sensitive microscopic experiments with tubulin-GFP (green fluorescent pro-
tein) and actin-GFP expressing HUH7 cells. This enabled the visualization of microtubule
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(a) Untreated cell (b) TPPS2a-treated cell
Figure 6.1: The influence of TPPS2a on tubulin-GFP expressing cells. For both a control (a) and
a TPPS2a-treated (b) cell the first 175 frames from a video sequence (acquisition time: 500 ms)
were averaged. For the control cell the obtained image is blurred, for the TPPS2a-treated cell
single microtubule strands can be distinguished. Scale bar: 10 µm.
movement and loss of movement in untreated and photosensitizer-treated cells, respectively.
Tubulin-GFP and actin-GFP expressing HUH7 cells were seeded 48 hours before measurement
in a density of 1.0 · 104 cells per well, on a collagen A-coated LabTek chambered cover glass.
After 24 hours, the medium was changed in the dark to medium containing 0.025 µg/ml
TPPS2a and in some cases 62.5 µg/ml Alexa Fluor Dextran (AFD), labeled with the Alexa Fluor
647 dye. The medium of control cells was changed to medium without photosensitizer. 12–
16 hours later the cells were washed three times in the dark with CO2-independent medium
to remove residual TPPS2a. Since illumination of the cells should be avoided, the samples
were handled in aluminium foil before measurement and subsequently placed on a heated
microstage (37◦C) and imaged.
In the following experiments, the photosensitizer was not activated by the 405 nm laser,
but by 488 nm laser light for the following reason. GFP is excited at 488 nm and its emission
lies in the range of 500–550 nm (see section 3.3.2). The intensity of the GFP fluorescence
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strongly depends on the amount of GFP expressed in the cells. To visualize microtubules and
actin filaments, the intensity of the 488 nm laser light was increased by a factor of 10–100
compared to the endosomal release experiments described in the last chapter. As a conse-
quence of this, the photosensitizer was activated with the 488 nm laser, since at this wave-
length TPPS2a shows weak absorption (figure 5.2a). This implies that differentiation between
visualization of the microtubules and activation of the photosensitizer was impossible.
The effect of TPPS2a incubation and activation on microtubules is presented in figure 6.1. For
both a control and a TPPS2a-treated cell, the first 175 frames from a video sequence, recorded
with an acquisition time of 500 ms, were averaged and the resulting image is presented.
For the untreated cell the obtained image is blurred (figure 6.1a). Individual strands cannot
be distinguished. In untreated cells microtubules show the typical bending and buckling
caused by polymerization and depolymerization. This movement results in a blur when the
fluorescence intensity of several frames from a video sequence is averaged. In contrast, in
the averaged image of the photosensitizer-treated cell, single microtubules can be identified
(figure 6.1b). Microtubule motion was largely absent in this case and thus averaging of
images does not result in blur. This suggests that microtubule motion is inhibited by TPPS2a.
Remarkably, in both the untreated and TPPS2a-treated cell an intact microtubule network was
observed, which remained intact during observation.
In cases where cells were incubated with TPPS2a and Alexa Fluor Dextran (AFD) inhibition
of microtubule movement was observed before endosomal release of AFD took place. This
suggests that inhibition of microtubule dynamics was not induced by the endosomal release
process itself nor by free TPPS2a released upon endosomal release, but resulted from direct
interaction of the photosensitizer with microtubules before cargo release.
Inhibition of microtubule dynamics was also observed after 2 hours of photosensitizer
incubation in the dark. After 6 hours of re-incubation in photosensitizer-free medium no
renewed movement was detected.
Whether the microtubule movement was inhibited already before photosensitizer activa-
tion could not be distinguished. First, due to the high intensity of the 488 nm laser, imaging
of the microtubules implied photosensitizer activation. Therefore, imaging and activation of
the photosensitizer could not be separated. Second, to determine motion during a movie, sev-
eral consecutive frames are necessary: one single frame does not show movement. During
imaging of these frames, the photosensitizer was activated because of the aforementioned
reason and thus inhibition of microtubule motion before photosensitizer activation could not
be distinguished.
These observations suggest a direct contact between photosensitizer and microtubules. Ob-
viously, for this to happen the photosensitizer has to be present in the cytosol. Two possi-
ble mechanisms exist for TPPS2a to get into the cytosol and intervene with the microtubule
dynamics. The first possibility is that TPPS2a is released from the endosome upon photosen-
sitizer activation and rapidly spreads out throughout the cytosol. Since we have seen that
microtubule dynamics were absent before endosomal release of dextran, this does not seem
a probable mechanism.
The second possibility is that during the long incubation time TPPS2a penetrates directly
through either the cell membrane or the endosomal membrane to get into the cytosol. Al-
though little photosensitizer is expected in the cytosol due to the preferential incorporation
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(a) Untreated actin-GFP expressing cell
(b) TPPS2a-treated actin-GFP expressing cell
Figure 6.2: The influence of TPPS2a on actin-GFP expressing cells. For both a control (a) and a
TPPS2a-treated (b) cell two images from a movie, recorded with 500 ms acquisition, are shown.
Actin stress fibers are observed in both cases. No influence of the photosensitizer is observed.
Scale bar: 10 µm.
74
R5  R9
in membranes [204], the 12 hours incubation time may have resulted in penetration of some
photosensitizer through the membrane. This behavior was observed for the photosensitizer
TPPS4 where indirect evidence was given for localization of the photosensitizer in the cytosol
and the nucleus [205].
Once in the cytosol, again two mechanisms exist to influence the microtubule dynamics.
First, photoactivation may induce singlet oxygen production which in turn could react with
microtubules. Second, direct binding of the photosensitizer to tubulin may inhibit polymer-
ization and/or depolymerization processes. In this case activation of the photosensitizer is
not necessary to inhibit microtubule motion.
Since inhibition of microtubule assembly is a well-known effect of porphyrins in the dark
(without photosensitizer activation) [201], the latter process is expected to play the major role.
As mentioned above, porphyrins bind to tubulin heterodimers and inhibit polymerization of
free tubulin dimers. This may explain the absence of microtubule dynamics.
Since an intact microtubule network was observed after 12 hours of incubation and
remained visible during the observation time, we suggest that depolymerization of micro-
tubules does not occur.
In short, the data suggest that TPPS2a can penetrate membranes to a certain amount in the
dark. The cytosolic pool of TPPS2a can bind to tubulin heterodimers resulting in distorted
microtubule dynamics.
After characterizing the effect of TPPS2a on microtubules, the influence on the actin cytoskele-
ton was examined. In figure 6.2a two images from a movie, recorded with an acquisition
time of 500 ms are shown. Figure 6.2a shows a control cell, incubated without photosensi-
tizer. The stress fibers are easily recognized and the cytosolic fluorescence represents actin
monomers. Figure 6.2b represents a TPPS2a-treated cell. In this figure also cellular stress
fibers are visible, although less distinct than for the control cell. This difference does not
necessarily represent an effect of the photosensitizer on the cell. The amount of stress fibers
differs per cell and per region of the cell. Stress fibers are especially abundant on the ad-
hesion site of the cell. Changing the focal plane of the microscope thus results in different
representations of the stress fibers. These observations therefore do not provide evidence for
an influence of TPPS2a on the actin cytoskeleton.
6.2 Rab5 and Rab9
The original motivation for experiments with Rab5- and Rab9-GFP expressing cells was to
verify the location of TPPS2a. Rab5 and Rab9 are proteins that are expressed on early and
late endosomes, respectively (see section 2.4). Thus, colocalization of the photosensitizer
autofluorescence with Rab5-GFP and Rab9-GFP would provide information on localization of
TPPS2a in early or late endosomes. Unfortunately, colocalization was ambiguous due to the
low fluorescence intensity of TPPS2a.
Nonetheless, an unexpected effect was observed upon excitation of Rab5-GFP and Rab9-
GFP structures. For cells incubated with TPPS2a the endosomal fluorescence quickly vanished
upon excitation with 488 nm laser light and the GFP signal of the endosomes dropped to
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(a) TPPS2a-treated Rab5-GFP expressing cell
(b) Untreated Rab5-GFP expressing cell
Figure 6.3: The influence of TPPS2a activation on Rab5-GFP expressing cells. For both a TPPS2a-
treated (a) and a control (b) cell two images from a movie, recorded with 500 ms acquisition
time under exactly the same experimental conditions and camera settings, are shown. Single
endosomes can be distinguished for the TPPS2a-treated cell at t = 0 s but have disappeared after
120 s. For the control cell endosomal fluorescence remains visible after 120 s. Scale bar: 5 µm.
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background level.
Rab5- and Rab9-GFP expressing cells were seeded and treated similarly as described in the
last section. It has to be noted that in the following experiments, the 405 nm laser was
not used to activate the photosensitizer. Just as for the excitation of tubulin-GFP and actin-
GFP, the intensity of the 488 nm laser was such that the photosensitizer was activated at this
wavelength.
The effect of 488 nm excitation on Rab5-GFP expressing cells incubated overnight with TPPS2a
is shown in figure 6.3a. The first image shows the cell directly after start of the illumination.
The cell shows a high cytosolic background which indicates the boundary of the cell and the
nucleus. No background fluorescence is observed within the cell nucleus. Single fluorescent
structures represent GFP-expressing endosomes. After 120 seconds of illumination the signal
of the endosomes has dropped to background level: single fluorescent endosomes cannot be
detected anymore.
To exclude the possibility of GFP bleaching by the 488 nm laser, the experiment was
repeated without TPPS2a. Figure 6.3b shows an untreated Rab5-GFP expressing cell. The
images were selected from a movie, recorded with an acquisition time of 500 ms under
exactly the same experimental conditions and camera settings as the TPPS2a-treated cell. In
this case fluorescent endosomes are distinguished at t = 0 s as well as at t = 120 s. Single
endosomes show a slight decrease in fluorescence intensity, most probably due to bleaching
of GFP by laser light. The cytosolic background is lower than in the case of photosensitizer-
treated cells.
A similar effect was observed for Rab9-GFP expressing cells. An example of a TPPS2a-
treated and a control cell is presented in figure 6.4. For both cells single endosomes can
be distinguished at the start of illumination. After 25 seconds, the single endosomes in the
TPPS2a-treated cell have disappeared and only cytosolic background fluorescence is visible
(figure 6.4a), whereas in the untreated cell single endosomes can easily be recognized (fig-
ure 6.4b).
These results show that the disappearance of single fluorescent structures in TPPS2a-treated
cells is due to the activation of TPPS2a rather than to bleaching of GFP by laser. For both Rab5-
and Rab9-GFP expressing cells incubated with TPPS2a endosomal structures were detected
immediately after start of illumination. This strongly indicates that the disappearance of
fluorescent structures is dependent on singlet oxygen, generated upon illumination, and is
not due to interaction of the photosensitizer itself with the Rab proteins.
To understand the influence of photosensitizer activation on Rab5 and Rab9 we first have to
look at the mechanism of Rab protein membrane binding. Rab proteins are small GTPases
that bind to the membrane of a specific compartment [206]. They play a role in vesicle fusion
and transport [89,207]. In the cytosol, Rab proteins are present in a GDP-bound conformation
[208]. Binding to a GDI protein (GDP Dissociation Inhibitor) is necessary to deliver the Rab-
GDP complex to the target membrane. In the membrane GDP is replaced by GTP which results
in stable binding of the protein to the membrane [209]. Rab proteins can thus switch between
a membrane-bound conformation and a cytosolic conformation. The observed disappearance
of single fluorescent structures and the increased cytosolic fluorescence may therefore be
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(a) TPPS2a-treated Rab9-GFP expressing cell
(b) Untreated Rab9-GFP expressing cell
Figure 6.4: The influence of TPPS2a activation on Rab9-GFP expressing cells. For both a TPPS2a-
treated (a) and a control (b) cell two images from a movie, recorded with 500 ms acquisition
time under exactly the same experimental conditions and camera settings, are shown. Endoso-
mal fluorescence is visible at t = 0 s but has disappeared after 25 s for the TPPS2a-treated cell.
For the control cell single endosomes can be distinguished at the start of illumination and after
25 s. Scale bar: 10 µm.
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interpreted as the transition of Rab proteins from their membrane-bound conformation to
their cytosolic form.
An obvious question now concerns the cause of this change in conformation. Rab pro-
teins bind to the membrane by geranylgeranylation of the two C-terminal cysteins [210]. The
geranylgeranylgroup integrates into the membrane resulting in stable binding. One possible
explanation why Rab5 and Rab9 proteins transform to their cytosolic conformation might
be singlet oxygen-induced damage of the cystein residues connecting Rab protein and ger-
anylgeranylgroup. Cystein is one of the amino acids that are easily damaged by singlet oxy-
gen [199, 211]. Since TPPS2a accumulates in the membrane of early and late endosomes and
the diffusion radius of singlet oxygen is only 50 nm [106], the concentration of singlet oxy-
gen is highest closest to the membrane. The cystein residues are therefore easily accessible
to singlet oxygen.
6.3 Stop of endosomal motion
An additional cellular effect of the photosensitizer was revealed during the experiments de-
scribed in chapter 5. Since the intensity of the 488 nm laser used in those experiments was
reduced compared to the aforementioned experiments, the 405 nm laser was used to induce
photosensitizer activation. Endosomal motion stopped suddenly and completely upon photo-
sensitizer activation, before the endosomal cargo was released into the cytosol. This effect
was observed independent of endosomal cargo.
To illustrate this effect trajectories of the endosomal movement were generated as described
before (section 3.5) and are presented in figure 6.5a. The corresponding instantaneous ve-
locities of the trajectories and their mean square displacements were plotted versus time in
figure 6.5b and figure 6.5c, respectively. In the first part of the trajectories, the endosomes
move in an area of about 8 µm in diameter. In the corresponding instantaneous velocity plots
velocities of up to 2 µm/s are observed. For all tracks directed movement is indicated by the
quadratic dependence of 〈r2〉 on ∆t in the mean square displacement plot.
After start of 405 nm illumination, marked by black arrows in figure 6.5a and figure 6.5b,
endosomal motion ceased in all tracks. This is illustrated in the trajectories by a reduction
of the area of movement from 8 µm to 2 µm in diameter. In the velocity plot a sudden
decrease in velocity to less than 0.3 µm/s is depicted. After 65 seconds the endosomes could
not be tracked further, because their fluorescent cargo was released into the cytosol. For cells
incubated with photosensitizer and particles for only two hours the same effect was observed.
The time point of endosomal stalling and endosomal release was strongly dependent on
the laser intensity. Higher laser intensity induced earlier onset of those events. Importantly,
the order of these events - motion, stop of motion, and release of cargo - was always the same.
In sharp contrast to the stop of microtubule movement, interpreted as a dark effect (without
photosensitizer activation), stop of endosomal motion was only induced by illumination with
the 405 nm laser. Therefore this event seems to be dependent on the formation of singlet
oxygen.
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(a) Trajectories
(b) Instantaneous velocity plot (c) Mean square displacement
Figure 6.5: Illustration of stop of endosomal motion for three particles. Upon 405 nm illu-
mination (marked with black arrows), a reduction in the area of movement is observed in the
trajectories (a) resulting in a decrease in instantaneous velocities (b). Before 405 nm illumina-
tion the particles showed directed movement (c). Scale bar (a): 2 µm.
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The inhibition of active transport along microtubules was not caused by photochemical dam-
age of microtubules as the experiments with tubulin-GFP cells described in section 6.1 showed
an intact microtubule cytoskeleton upon photosensitizer activation. This indicates that endo-
somal stalling may be induced by singlet oxygen damage and may involve motor proteins.
Singlet oxygen has a limited diffusion radius (50 nm) from its site of generation [106]. As
TPPS2a is attached to endosomal membranes and presumably to microtubules, the generated
singlet oxygen could interact at some point in the link between microtubules and endosomal
transport. This may occur either by direct damage of motor proteins or by destruction of
proteins involved in linkage of motor proteins to membranes.
It has been shown that Rab proteins play a role in vesicle mobility and fusion [89, 207].
They are associated with the link between motor proteins and endosomes [207, 212, 213].
As described in section 6.2 photosensitizer activation may induce relocation of Rab proteins
from the endosomal membrane to the cytosol. The dissociation of Rab proteins from endo-
somes could thus result in loss of motor protein connection with the endosome. This would
lead to an immediate stop of endosomal motion.
6.4 Summary
In this chapter the side effects of TPPS2a on cellular compartments were studied. These side
effects may either be classified as resulting from intracellular singlet oxygen generation or
from direct binding to TPPS2a.
A stop of microtubule motion was observed that was interpreted as reduced polymer-
ization of tubulin. Since an intact microtubule network was observed a decrease in depoly-
merization was not probable. A dark effect of porphyrins by binding to tubulin has been
demonstrated before. This requires a direct interaction of photosensitizer and microtubules
which may occur via penetration through the plasma membrane during the 12 hours incuba-
tion period.
A second side effect concerned Rab proteins. Rab5 and Rab9 are early and late endosome
markers respectively and were transformed into their cytosolic form upon photosensitizer ac-
tivation. Singlet oxygen may damage the link between Rab protein and endosomal membrane
and thus the Rab protein may dissociate from the membrane and may be transported into the
cytosol.
For the third side effect a clear dependence on photosensitizer activation was detected.
Immediately after illumination with 405 nm laser light, stop of endosomal motion was ob-
served. This stop was observed before cargo release occurred. Since Rab proteins connect
endosomes to motor proteins and dissociation of the Rab proteins from the endosomal mem-
brane was observed, the stop of endosomal motion may be caused by a loss of connection
between endosomes and Rab proteins.
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